JPH05155850A - Azetidine-2-one derivative - Google Patents

Azetidine-2-one derivative

Info

Publication number
JPH05155850A
JPH05155850A JP3324737A JP32473791A JPH05155850A JP H05155850 A JPH05155850 A JP H05155850A JP 3324737 A JP3324737 A JP 3324737A JP 32473791 A JP32473791 A JP 32473791A JP H05155850 A JPH05155850 A JP H05155850A
Authority
JP
Japan
Prior art keywords
mmol
group
compound
derivative
azetidin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP3324737A
Other languages
Japanese (ja)
Other versions
JP2958834B2 (en
Inventor
Takashi Miura
孝志 三浦
Toshiyuki Murayama
俊幸 村山
Akifumi Yoshida
昭文 吉田
Toyohiko Kobayashi
東洋彦 小林
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takasago International Corp
Original Assignee
Takasago International Corp
Takasago Perfumery Industry Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takasago International Corp, Takasago Perfumery Industry Co filed Critical Takasago International Corp
Priority to JP3324737A priority Critical patent/JP2958834B2/en
Priority to DE69231883T priority patent/DE69231883T2/en
Priority to EP92310901A priority patent/EP0546742B1/en
Priority to KR1019920023554A priority patent/KR100253715B1/en
Priority to US07/987,779 priority patent/US5371214A/en
Publication of JPH05155850A publication Critical patent/JPH05155850A/en
Priority to US08/277,319 priority patent/US5574152A/en
Application granted granted Critical
Publication of JP2958834B2 publication Critical patent/JP2958834B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

PURPOSE:To provide a new compound useful as an intermediate for synthesizing 1beta-alkylcarbapenem-based antibacterial agents. CONSTITUTION:A compound of formula I (R<1> and R<2> are each alkyl, alkenyl or aralkyl; R<3> is lower alkyl; R<4> is H or protected hydroxyl group; R<5> is H or protected amino), e.g. a compound of formula III (TBDMS is t- butyldimethylsilyl). The compound of the formula I can be obtained, for example, by reaction of a compound of formula III with a compound of formula IV in a solvent (e.g. THF) in the presence of a base such as sodium methylate.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【産業上の利用分野】本発明は、種々の1β−アルキル
カルバペネム系抗菌剤の合成中間体として有用なアゼチ
ジン−2−オン誘導体に関する。
TECHNICAL FIELD The present invention relates to an azetidin-2-one derivative useful as a synthetic intermediate for various 1β-alkylcarbapenem antibacterial agents.

【0002】[0002]

【従来の技術及び発明が解決しようとする課題】カルバ
ペネム系抗菌剤は、グラム陽性菌から緑膿菌を含むグラ
ム陰性菌にわたる広範囲の細菌に対して強い抗菌力を有
する優れた抗菌剤であるため、近年、活発に開発がなさ
れている。式(2)
BACKGROUND OF THE INVENTION Carbapenem antibacterial agents are excellent antibacterial agents having a strong antibacterial activity against a wide range of bacteria ranging from Gram-positive bacteria to Gram-negative bacteria including Pseudomonas aeruginosa. In recent years, active development has been made. Formula (2)

【0003】[0003]

【化2】 [Chemical 2]

【0004】で表されるチエナマイシンなどカルバペネ
ム骨格の1位に置換基を有していないカルバペネム類は
高濃度では化学的に不安定であり、しかも腎デヒドロペ
プチダーゼにより容易に代謝されてしまうという欠点を
有するが、1位にβ−配置のアルキル基を導入すると安
定性が増し、腎デヒドロペプチダーゼ阻害剤を配合する
ことなく単独使用が可能となる。このため、現在では1
β−アルキルカルバペネム系抗菌剤の開発に力が入れら
れており、その合成中間体となる一般式(3β)
Carbapenems such as thienamycin, which do not have a substituent at the 1-position of the carbapenem skeleton, are chemically unstable at high concentrations and are easily metabolized by renal dehydropeptidase. However, when a β-configured alkyl group is introduced into the 1-position, the stability is increased, and it can be used alone without compounding a renal dehydropeptidase inhibitor. For this reason, 1
Development of β-alkylcarbapenem antibacterial agents has been focused on, and the general formula (3β), which is a synthetic intermediate, has been developed.

【0005】[0005]

【化3】 [Chemical 3]

【0006】(式中、R3は低級アルキル基を示し、R4
は水素原子又は水酸基の保護基を示す)で表される4−
〔(R)−1−カルボキシアルキル〕アゼチジン−2−
オン誘導体の合成法の開発も盛んに行われている。
(In the formula, R 3 represents a lower alkyl group, and R 4
Represents a hydrogen atom or a hydroxyl-protecting group) 4-
[(R) -1-Carboxyalkyl] azetidine-2-
The development of synthetic methods for on-derivatives is also actively carried out.

【0007】この化合物(3β)の合成法としては、多
くの報告がなされているが、特に一般式(4)
Many reports have been made as to the method of synthesizing this compound (3β), but in particular the general formula (4)

【0008】[0008]

【化4】 [Chemical 4]

【0009】(式中、R4は前記と同じ意味を示し、A
cはアセチル基を示す)で表される4−アセトキシアゼ
チジン−2−オン誘導体の4位を、種々の求核剤により
アルキル化することにより、側鎖を導入する方法が最も
期待されており、プロピオン酸エステルエノラートによ
るアルキル化〔C.U.Kimら;Tetrahedr
on Lett.,28(5)507−510(198
7)、T.Chidaら;Chem.Lett.,13
43−1346(1985)、T.Shibataら;
Tetrahedron Lett.,26(39)4
739−4742(1985)〕、プロピオン酸イミド
のエノラートによるアルキル化〔Y.Nagaoら;
J.Am.Chem.Soc.,108,4673−4
675(1986)、長尾善光;化学,42(3)19
0−196(1987)、L.M.Fuentesら;
J.Am.Chem.Soc.,108,4675−4
676(1986)、R.Dezielら;Tetra
hedron Lett.,27(47)5687−5
690(1986)、Y.Itoら;Tetrahed
ron Lett.,28(52)6625−6628
(1987)、プロピオン酸チオールエステルエノラー
トによるアルキル化〔M.Endoら;Can,J.C
hem.,65,2140−2145(1987)、
C.U.Kimら;Tetrahedron Let
t.,28(5)507−510(1987)、A.M
artelら;Can.J.Chem.,66,153
7−1539(1988)〕などが報告されている。化
合物(3β)のその他の合成法としては、例えば化合物
(5)
(Wherein R 4 has the same meaning as described above, and A 4
c represents an acetyl group), and a method of introducing a side chain by alkylating the 4-position of the 4-acetoxyazetidin-2-one derivative represented by various nucleophiles is most expected. Alkylation with propionate enolate [C. U. Kim et al .; Tetrahedr
on Lett. , 28 (5) 507-510 (198).
7), T. Chida et al .; Chem. Lett. , 13
43-1346 (1985), T.W. Shibata et al .;
Tetrahedron Lett. , 26 (39) 4
739-4742 (1985)], alkylation of propionimide with an enolate [Y. Nagao et al .;
J. Am. Chem. Soc. , 108 , 4673-4
675 (1986), Yoshimitsu Nagao; Chemistry, 42 (3) 19
0-196 (1987), L.A. M. Fuentes et al .;
J. Am. Chem. Soc. , 108 , 4675-4
676 (1986), R.I. Deziel et al .; Tetra
hedron Lett. , 27 (47) 5687-5.
690 (1986), Y. Ito et al .; Tetrahed
ron Lett. , 28 (52) 6625-6628.
(1987), alkylation with a propionic acid thiol ester enolate [M. Endo et al .; Can, J .; C
hem. , 65 , 2140-2145 (1987),
C. U. Kim et al .; Tetrahedron Let
t. , 28 (5) 507-510 (1987), A.A. M
artel et al .; Can. J. Chem. , 66 , 153
7-1539 (1988)] and the like have been reported. Other synthetic methods of compound (3β) include, for example, compound (5)

【0010】[0010]

【化5】 [Chemical 5]

【0011】(式中、R4は前記と同じ意味を示す)を
リチウムジイソプロピルアミドによりアルキル化する方
法〔D.H.Shih,Heterocycles,
(1)29−40(1984)、化合物(6)
(Wherein R 4 has the same meaning as described above) is alkylated with lithium diisopropylamide [D. H. Shih, Heterocycles, 2
1 (1) 29-40 (1984), compound (6)

【0012】[0012]

【化6】 [Chemical 6]

【0013】(式中、R4は前記と同じ意味を示し、R5
は水素原子又はアミノ基の保護基を示し、R6はアルキ
ル基、カルボキシ基又はアルコキシカルボニル基を示
す)のエキソメチレン基を接触還元又は特定の触媒によ
り不斉還元する方法〔特開昭58−26887号公報、
C.U.Kimら;Tetrahedron Let
t.,28(5)507−510(1987)、T.O
htaら;J.Org.Chem.,52,3176−
3178(1987)、T.Iimoriら;Tetr
ahedron Lett.,27(19)2149−
2152(1986)〕などがあり、総説〔伊藤芳雄
ら;有機合成化学、47(7)606−618(198
9)〕に報告されている。
(In the formula, R 4 has the same meaning as described above, and R 5
Represents a hydrogen atom or a protecting group for an amino group, and R 6 represents an alkyl group, a carboxy group or an alkoxycarbonyl group), or asymmetric reduction by a specific catalyst [JP-A-58- 26887 publication,
C. U. Kim et al .; Tetrahedron Let
t. , 28 (5) 507-510 (1987), T.S. O
Hta et al .; Org. Chem. , 52 , 3176-
3178 (1987), T.S. Iimori et al .; Tetr
ahedron Lett. , 27 (19) 2149-
2152 (1986)], etc., and a review [Yoshio Ito et al .; Synthetic Organic Chemistry, 47 (7) 606-618 (198).
9)].

【0014】これらの方法で得られる化合物(3β)
は、ほとんどの場合、その立体異性体である化合物(3
α)
Compound (3β) obtained by these methods
Is a compound (3
α)

【0015】[0015]

【化7】 [Chemical 7]

【0016】(式中、R3及びR4は前記と同じ意味を示
す)と特定の割合で混合した化合物(3)
Compound (3) mixed with (in the formula, R 3 and R 4 have the same meanings as described above) in a specific ratio

【0017】[0017]

【化8】 [Chemical 8]

【0018】(式中、R3及びR4は前記と同じ意味を示
す)として得られるが、このα−配置のアルキル基を有
する化合物(3α)は、例えば、D.H.Shihら;
Heterocycles,21(1)29−40(1
984)に記載されている方法により異性化を行えば、
目的とするβ−配置のアルキル基を有する化合物(3
β)とすることができる。
(Wherein R 3 and R 4 have the same meanings as described above), the compound (3α) having an α-configured alkyl group can be obtained, for example, from D.I. H. Shih et al .;
Heterocycles, 21 (1) 29-40 (1
If the isomerization is carried out by the method described in 984),
A compound having a desired β-configuration alkyl group (3
β).

【0019】しかしながら、前記した化合物(3)及び
化合物(3β)の合成法は、特殊で高価な試薬を用いた
り、反応温度が極めて低かったり、高価な金属や毒性の
ある金属を触媒として使用するなど、大量に合成するの
に適した方法ではなく、実際に工業的規模では製造され
ていないのが現状であった。
However, in the method of synthesizing the compound (3) and the compound (3β), a special and expensive reagent is used, a reaction temperature is extremely low, and an expensive metal or a toxic metal is used as a catalyst. However, it is not a method suitable for large-scale synthesis, and it has not been actually manufactured on an industrial scale.

【0020】従って、化合物(3)、特に、1β−アル
キルカルバペネム系抗菌剤の合成中間体としてより利用
価値の高い、β−配置のアルキル基を有する化合物(3
β)を効率よく製造する方法の開発が望まれていた。
Therefore, the compound (3), especially the compound (3 having an β-configured alkyl group, which is more useful as a synthetic intermediate for 1β-alkylcarbapenem antibacterial agents, is useful.
It was desired to develop a method for efficiently producing β).

【0021】[0021]

【課題を解決するための手段】かかる実情において、本
発明者らは鋭意研究を行った結果、アゼチジン−2−オ
ン誘導体の4位にマロン酸誘導体が結合した化合物が、
化合物(3)及び化合物(3β)の合成中間体として有
用であることを見出し、本発明を完成した。
Under these circumstances, as a result of intensive studies by the present inventors, a compound in which a malonic acid derivative was bonded to the 4-position of an azetidin-2-one derivative was
They have found that they are useful as synthetic intermediates for compound (3) and compound (3β), and completed the present invention.

【0022】すなわち、本発明は、一般式(1)That is, the present invention has the general formula (1)

【0023】[0023]

【化9】 [Chemical 9]

【0024】(式中、R1及びR2は同一又は異なって、
それぞれアルキル基、アルケニル基又はアラルキル基を
示し、R3は低級アルキル基を示し、R4は水素原子又は
水酸基の保護基を示し、R5は水素原子又はアミノ基の
保護基を示す)で表されるアゼチジン−2−オン誘導体
を提供するものである。
(Wherein R 1 and R 2 are the same or different,
Each represents an alkyl group, an alkenyl group or an aralkyl group, R 3 represents a lower alkyl group, R 4 represents a hydrogen atom or a hydroxyl group protecting group, and R 5 represents a hydrogen atom or an amino group protecting group) And an azetidin-2-one derivative.

【0025】本発明のアゼチジン−2−オン誘導体は前
記一般式(1)で表されるものであり、式中、R1及び
2で示されるアルキル基としては、例えばメチル基、
エチル基、n−プロピル基、イソプロピル基、n−ブチ
ル基、tert−ブチル基のような直鎖又は分岐鎖のア
ルキル基;シクロペンチル基、シクロヘキシル基、メン
チル基、フェンチル基、ボルニル基のような単環又は多
環のアルキル基が挙げられ、アルケニル基としては、例
えばビニル基、アリル基、2−ブテニル基、2−メチル
−2−プロペニル基のような直鎖又は分岐鎖のアルケニ
ル基が挙げられ、アラルキル基としては、例えばベンジ
ル基、ベンズヒドリル基等が挙げられる。また、R3
示される低級アルキル基としては、例えばメチル基、エ
チル基、n−プロピル基等が挙げられ、R4で示される
水酸基の保護基としては、例えばトリメチルシリル基、
tert−ブチルジメチルシリル基のような三置換シリ
ル基;アセチル基のようなアシル基;ベンジル基のよう
なアラルキル基等が挙げられ、R5で示されるアミノ基
の保護基としては、例えばトリメチルシリル基、トリエ
チルシリル基、tert−ブチルジメチルシリル基、メ
チルジフェニルシリル基のような三置換シリル基;ベン
ジル基、p−メトキシベンジル基、p−tert−ブチ
ルベンジル基、3,4−ジメチルベンジル基、フェネチ
ル基、ベンズヒドリル基のような芳香環上に置換基を有
していてもよいアラルキル基;テトラヒドロピラニル
基、メトキシメチル基のようなアルコキシアルキル基等
が挙げられる。
The azetidin-2-one derivative of the present invention is represented by the above-mentioned general formula (1). In the formula, the alkyl group represented by R 1 and R 2 is, for example, a methyl group,
A linear or branched alkyl group such as an ethyl group, an n-propyl group, an isopropyl group, an n-butyl group, and a tert-butyl group; a single group such as a cyclopentyl group, a cyclohexyl group, a menthyl group, a fentyl group, and a bornyl group. Examples thereof include a cyclic or polycyclic alkyl group, and examples of the alkenyl group include a linear or branched alkenyl group such as a vinyl group, an allyl group, a 2-butenyl group, and a 2-methyl-2-propenyl group. Examples of the aralkyl group include a benzyl group and a benzhydryl group. Further, examples of the lower alkyl group represented by R 3 include a methyl group, ethyl group and n-propyl group, and examples of the protective group for the hydroxyl group represented by R 4 include a trimethylsilyl group,
A tri-substituted silyl group such as a tert-butyldimethylsilyl group; an acyl group such as an acetyl group; an aralkyl group such as a benzyl group. Examples of the amino group protecting group represented by R 5 include a trimethylsilyl group. , Triethylsilyl group, tert-butyldimethylsilyl group, trisubstituted silyl group such as methyldiphenylsilyl group; benzyl group, p-methoxybenzyl group, p-tert-butylbenzyl group, 3,4-dimethylbenzyl group, phenethyl group Group, an aralkyl group which may have a substituent on the aromatic ring such as a benzhydryl group; an alkoxyalkyl group such as a tetrahydropyranyl group and a methoxymethyl group.

【0026】これらのアゼチジン−2−オン誘導体
(1)は、一般式(1)においてR5が水素原子である
場合(以下、「アゼチジン−2−オン誘導体(1a)」
と記載する)は、例えばR.Joyeauらの方法
〔J.Chem.Soc.,Perkin Tran
s.I,1899−1907(1987)、Tetra
hedron Lett.,30(3)337−340
(1989)〕に準じ、下記式に従って4−アセトキシ
アゼチジン−2−オン誘導体(4)に、マロン酸誘導体
(7)を反応させることにより製造される。
These azetidin-2-one derivatives (1) are represented by the formula (1) in which R 5 is a hydrogen atom (hereinafter referred to as "azetidin-2-one derivative (1a)").
Is described in, for example, R.I. The method of Joyeau et al. [J. Chem. Soc. , Perkin Tran
s. I, 1899-1907 (1987), Tetra.
hedron Lett. , 30 (3) 337-340.
(1989)], the 4-acetoxyazetidin-2-one derivative (4) is reacted with the malonic acid derivative (7) according to the following formula.

【0027】[0027]

【化10】 [Chemical 10]

【0028】(式中、R1、R2、R3、R4、及びAcは
前記と同じ意味を示す)
(In the formulae, R 1 , R 2 , R 3 , R 4 and Ac have the same meanings as described above)

【0029】すなわち、金属カリウム、金属ナトリウ
ム、金属リチウムのようなアルカリ金属;水素化ナトリ
ウムのようなアルカリ金属水素化物;ブチルリチウムの
ようなアルカリ金属アルキル化物;カリウム−tert
−ブチラート、ナトリウムエチラート、ナトリウムメチ
ラートのようなアルカリ金属アルコキシド;水酸化カリ
ウム、水酸化ナトリウムのようなアルカリ金属水酸化
物;炭酸カリウムのようなアルカリ金属炭酸塩等で活性
化したマロン酸誘導体(7)溶液に、4−アセトキシア
ゼチジン−2−オン誘導体(4)を加え、−60〜40
℃、特に好ましくは室温で0.5〜15時間反応させる
ことにより製造される。ここで用いられる溶媒として
は、例えば水;メタノール、エタノールのようなアルコ
ール類;ジエチルエーテル、ジオキサン、テトラヒドロ
フランのようなエーテル類;アセトン;ジメチルホルム
アミド;あるいは水とこれらの有機溶媒との混合溶媒等
が挙げられるが、特に好ましくはテトラヒドロフランが
用いられる。反応化合物の比率は、4−アセトキシアゼ
チジン−2−オン誘導体(4)1モルに対し、マロン酸
誘導体(7)約1〜1.3モルとするのがよい。得られ
たアゼチジン−2−オン誘導体(1a)は、通常の方法
により抽出、洗浄、脱水等をした後、再結晶、カラムク
ロマトグラフィー等により精製することができる。
That is, alkali metals such as metal potassium, sodium metal and lithium; alkali metal hydrides such as sodium hydride; alkali metal alkylates such as butyl lithium; potassium-tert.
-Alkali metal alkoxides such as butyrate, sodium ethylate, sodium methylate; alkali metal hydroxides such as potassium hydroxide and sodium hydroxide; malonic acid derivatives activated with alkali metal carbonates such as potassium carbonate. (7) To the solution, 4-acetoxyazetidin-2-one derivative (4) was added, and -60 to 40
It is manufactured by reacting at 0 ° C., particularly preferably at room temperature for 0.5 to 15 hours. Examples of the solvent used here include water; alcohols such as methanol and ethanol; ethers such as diethyl ether, dioxane and tetrahydrofuran; acetone; dimethylformamide; or a mixed solvent of water and these organic solvents. However, tetrahydrofuran is particularly preferably used. The ratio of the reaction compound is preferably about 1 to 1.3 mol of the malonic acid derivative (7) with respect to 1 mol of the 4-acetoxyazetidin-2-one derivative (4). The obtained azetidin-2-one derivative (1a) can be purified by recrystallization, column chromatography and the like after extraction, washing, dehydration and the like by a usual method.

【0030】一般式(1)においてR5がアミノ基の保
護基である場合(以下、アゼチジン−2−オン誘導体
(1b)と記載する)は、前記した方法でR5が水素原
子であるアゼチジン−2−オン誘導体(1a)を得た
後、通常の方法によりアミノ基の保護基を導入すること
により製造される。
In the general formula (1), when R 5 is a protecting group for an amino group (hereinafter referred to as azetidin-2-one derivative (1b)), azetidine in which R 5 is a hydrogen atom is prepared by the method described above. After the 2-one derivative (1a) is obtained, it is produced by introducing an amino-protecting group by a conventional method.

【0031】このようにして得られる本発明のアゼチジ
ン−2−オン誘導体(1)は、下記式に従って通常の方
法により脱エステル及び脱炭酸を行うことにより、4−
(1−カルボキシアルキル)アゼチジン−2−オン誘導
体(3)とすることができる。
The azetidin-2-one derivative (1) of the present invention thus obtained is subjected to deesterification and decarboxylation according to the following formula by a conventional method to give 4-
It can be a (1-carboxyalkyl) azetidin-2-one derivative (3).

【0032】[0032]

【化11】 [Chemical 11]

【0033】(式中、R1、R2、R3、R4及びR5は前
記と同じ意味を示す)
(In the formula, R 1 , R 2 , R 3 , R 4 and R 5 have the same meanings as described above.)

【0034】この脱エステル及び脱炭酸反応は、例えば
通常の加水分解及び加熱反応によって行うことができ
る。すなわち、化合物(1)を水酸化ナトリウム、水酸
化カリウム、水酸化リチウム等の塩基の存在下で加水分
解し、次いで80〜120℃に加熱することにより脱炭
酸を行えばよい。
The deesterification and decarboxylation reactions can be carried out, for example, by ordinary hydrolysis and heating reactions. That is, the compound (1) may be hydrolyzed in the presence of a base such as sodium hydroxide, potassium hydroxide or lithium hydroxide, and then heated at 80 to 120 ° C. for decarboxylation.

【0035】R1及びR2が2−アルケニル基であるアゼ
チジン−2−オン誘導体(1)を原料として用いる場合
には、当該脱エステル及び脱炭酸反応は、前述の方法に
より行うこともできるが、例えばJ.Tsujiらの方
法〔TetrahedronLett.,(7)613
−616(1979)〕を応用して、アゼチジン−2−
オン誘導体(1)に、パラジウム化合物及びその配位子
となる化合物の存在下、ギ酸又はギ酸のアミン塩を加熱
還流下で1〜5時間を反応させることにより行えば、脱
エステル及び脱炭酸を一段階で行うことができ、好まし
い。ここで用いられるパラジウム化合物は、活性種であ
る0価のパラジウムを反応系内で生成させ得るものであ
ればよく、具体的には酢酸パラジウム、塩化パラジウ
ム、パラジウムアセチルアセトナートのような2価のパ
ラジウム化合物;トリベンジリデンジパラジウム、テト
ラキストリフェニルホスフィンパラジウムのような0価
のパラジウム化合物等が挙げられる。配位子としては、
トリエチルホスフィン、トリブチルホスフィンのような
トリアルキルホスフィン;トリフェニルホスフィン、ト
リトリルホスフィンのようなトリアリールホスフィン等
が挙げられる。ここで用いられる溶媒としては、例えば
1,4−ジオキサン、テトラヒドロフランのようなエー
テル類;トルエン;ベンゼン等を挙げることができる。
反応化合物の比率は、アゼチジン−2−オン(1)1モ
ルに対し、パラジウム化合物約0.01〜0.3モル、
ギ酸又はギ酸アミン塩約3〜15モルとするのがよい。
When the azetidin-2-one derivative (1) in which R 1 and R 2 are 2-alkenyl groups is used as a raw material, the deesterification and decarboxylation reactions can be carried out by the above-mentioned method. , J. The method of Tsuji et al. [Tetrahedron Lett. , (7) 613
-616 (1979)], azetidine-2-
The on-derivative (1) is reacted with formic acid or an amine salt of formic acid for 1 to 5 hours under heating and reflux in the presence of a palladium compound and a compound serving as a ligand thereof to perform deesterification and decarboxylation. It can be carried out in one step and is preferred. The palladium compound used here may be any compound that can generate 0-valent palladium, which is an active species, in the reaction system. Specifically, it is a divalent palladium compound such as palladium acetate, palladium chloride, or palladium acetylacetonate. Palladium compounds; trivalent dilidene dipalladium, zero-valent palladium compounds such as tetrakistriphenylphosphine palladium and the like can be mentioned. As a ligand,
Examples thereof include trialkylphosphines such as triethylphosphine and tributylphosphine; and triarylphosphines such as triphenylphosphine and tritolylphosphine. Examples of the solvent used here include ethers such as 1,4-dioxane and tetrahydrofuran; toluene; benzene and the like.
The ratio of the reaction compound is about 0.01 to 0.3 mol of the palladium compound with respect to 1 mol of azetidin-2-one (1),
Formic acid or amine salt of formic acid is preferably about 3 to 15 mol.

【0036】原料化合物が、一般式(1)においてR5
が水素原子であるアゼチジン−2−オン誘導体(1a)
である場合には、これらの脱エステル・脱炭酸反応によ
り得られる化合物(3)は、α−アルキル体(3α)が
優先的に得られる。最終目的物であるカルバペネム骨格
の1位のアルキル基の立体配置はβ−配置であるが、得
られたα−アルキル体(3α)は前記した公知の方法に
より異性化を行い、β−アルキル体(3β)とすること
ができる。
The starting compound is R 5 in the general formula (1).
Is an azetidin-2-one derivative (1a)
In the case of, the α-alkyl compound (3α) is preferentially obtained as the compound (3) obtained by the deesterification / decarboxylation reaction. The configuration of the alkyl group at the 1-position of the carbapenem skeleton, which is the final target product, is β-configuration. The obtained α-alkyl compound (3α) is isomerized by the above-mentioned known method to obtain the β-alkyl compound. It can be (3β).

【0037】一方、原料化合物が、一般式(1)におい
てR5がアミノ基の保護基である場合(以下、「アゼチ
ジン−2−オン誘導体(1b)」と記載する)には、前
記した脱エステル及び脱炭酸反応を行った後、当該アミ
ノ基の保護基を脱離せしめることにより、目的とする化
合物(3)を得ることができ、この場合は得られる化合
物(3)は、β−アルキル体(3β)が優先的に得られ
るので工業的利用価値が高く、好ましい。当該アミノ基
の保護基の脱離反応は、保護基の種類によって異なる
が、例えば保護基が三置換シリル基の場合には、希塩酸
のような弱酸を反応させればよい。また保護基が置換基
を有していてもよいベンジル基、フェネチル基、ベンス
ヒドリル基等の場合には、バーチの還元により液体アン
モニア中で金属ナトリウムと反応させればよい。
On the other hand, in the case where the starting compound is R 5 in the general formula (1) is a protecting group for an amino group (hereinafter, referred to as “azetidin-2-one derivative (1b)”), the above-mentioned removal is carried out. After carrying out the esterification and decarboxylation reaction, the target compound (3) can be obtained by removing the protective group of the amino group. In this case, the obtained compound (3) is a β-alkyl group. Since the body (3β) is preferentially obtained, it has a high industrial utility value, which is preferable. The elimination reaction of the protective group of the amino group varies depending on the type of the protective group, but when the protective group is a trisubstituted silyl group, a weak acid such as dilute hydrochloric acid may be reacted. When the protecting group is a benzyl group which may have a substituent, a phenethyl group or a benzhydryl group, it may be reacted with sodium metal in liquid ammonia by reduction of Birch.

【0038】[0038]

【実施例】次に、実施例及び参考例を挙げて、本発明を
さらに詳細に説明するが、本発明はこれらに限定される
ものではない。なお、以下の測定には次の機器を用い
た。 融点:MP−S3型(柳本商事株式会社製) 質量スペクトル(MS):M−80B質量分析計(イオ
ン化電圧:20eV)(株式会社日立製作所製) 赤外吸収スペクトル(IR):IR−810型(日本分
光工業株式会社製)1 H核磁気共鳴スペクトル(1H−NMR):AM−40
0型(400MHz)(ブルッカー社製) 内部標準物質:テトラメチルシラン
EXAMPLES Next, the present invention will be described in more detail with reference to Examples and Reference Examples, but the present invention is not limited thereto. The following equipment was used for the following measurements. Melting point: MP-S3 type (manufactured by Yanagimoto Corporation) Mass spectrum (MS): M-80B mass spectrometer (ionization voltage: 20 eV) (manufactured by Hitachi, Ltd.) Infrared absorption spectrum (IR): IR-810 type (Nippon Bunko Kogyo Co., Ltd.) 1 H nuclear magnetic resonance spectrum ( 1 H-NMR): AM-40
Type 0 (400 MHz) (Brooker) Internal standard substance: Tetramethylsilane

【0039】実施例1Example 1

【0040】[0040]

【化12】 [Chemical 12]

【0041】(式中、Acは前記と同じ意味を示し、T
BDMSはtert−ブチルジメチルシリル基を示す。
以下同様) テトラヒドロフラン50mlに60%水素化ナトリウム
2.52g(62.9mmol)を懸濁させ、室温で撹拌し
ながら、メチルマロン酸ジアリル(7−1)11.88
g(60.0mmol)をテトラヒドロフラン20mlに溶解
した溶液を20分かけて滴下した。さらに、2.5時間
撹拌した後、4−アセトキシアゼチジン−2−オン誘導
体(4−1)14.35g(50.0mmol)をテトラヒ
ドロフラン30mlに溶解した溶液を15分かけて滴下
し、室温で15時間反応を続けた。反応液に飽和塩化ア
ンモニウム水溶液30mlを加え撹拌、分液した後、得ら
れたテトラヒドロフラン層を飽和食塩水で洗浄、無水硫
酸マグネシウムで脱水し、溶媒を留去して粗結晶23.
5gを得た。ヘキサンを用いて再結晶を行い、白色結晶
のアゼチジン−2−オン誘導体(1a−1)18.03
g(収率85%)を得た。 融点;82-82.5℃ MS(m/e):426(M++1),410,368 IR(KBr)cm-1:1765,17351 H-NMR δ(CDCl3):0.07(s,6H),0.88(s,9H),1.14(d,J=6.
3Hz,3H),1.50(s,3H),3.03(m,1H),4.19(d,J=2.1,1H),4.2
1(m,1H),4.64(m,4H),5.27(m,2H),5.34(m,2H),5.88(m,2
H),5.96(broad s,1H)
(In the formula, Ac has the same meaning as described above, and T
BDMS represents a tert-butyldimethylsilyl group.
The same applies below) 2.52 g (62.9 mmol) of 60% sodium hydride was suspended in 50 ml of tetrahydrofuran, and diallyl methylmalonate (7-1) 11.88 was stirred with stirring at room temperature.
A solution of g (60.0 mmol) in 20 ml of tetrahydrofuran was added dropwise over 20 minutes. Further, after stirring for 2.5 hours, a solution of 14.35 g (50.0 mmol) of 4-acetoxyazetidin-2-one derivative (4-1) dissolved in 30 ml of tetrahydrofuran was added dropwise over 15 minutes at room temperature. The reaction was continued for 15 hours. After adding 30 ml of a saturated aqueous solution of ammonium chloride to the reaction mixture and stirring and separating the layers, the obtained tetrahydrofuran layer was washed with saturated brine and dehydrated with anhydrous magnesium sulfate, and the solvent was distilled off to give crude crystals.
5 g was obtained. Recrystallization was performed using hexane to give a white crystalline azetidin-2-one derivative (1a-1) 18.03.
g (yield 85%) was obtained. Melting point; 82-82.5 ° C MS (m / e): 426 (M + +1), 410,368 IR (KBr) cm -1 : 1765,1735 1 H-NMR δ (CDCl 3 ): 0.07 (s, 6H), 0.88 (s, 9H), 1.14 (d, J = 6.
3Hz, 3H), 1.50 (s, 3H), 3.03 (m, 1H), 4.19 (d, J = 2.1,1H), 4.2
1 (m, 1H), 4.64 (m, 4H), 5.27 (m, 2H), 5.34 (m, 2H), 5.88 (m, 2
H), 5.96 (broad s, 1H)

【0042】実施例2Example 2

【0043】[0043]

【化13】 [Chemical 13]

【0044】60%水素化ナトリウム1.12g(2
8.0mmol)にヘキサン5mlを加え撹拌した後、傾斜法
によりヘキサンを除去した。この手順を数回繰り返すこ
とにより洗浄した後、テトラヒドロフラン20mlを加
え、室温で撹拌しながら、メチルマロン酸ジエチル(7
−2)4.52g(26.0mmol)をテトラヒドロフラ
ン20mlに溶解した溶液を15分かけて滴下した。さら
に、30分間撹拌した後、4−アセトキシアゼチジン−
2−オン誘導体(4−1)5.74g(20.0mmol)
をテトラヒドロフラン20mlに溶解した溶液を10分か
けて滴下し、室温で1時間反応を続けた。反応液に飽和
塩化アンモニウム水溶液25mlを加え撹拌、分液した
後、得られたテトラヒドロフラン層を飽和食塩水で洗
浄、無水硫酸マグネシウムで脱水し、溶媒を留去して粗
結晶を得た。ヘキサンを用いて再結晶を行い、白色結晶
のアゼチジン−2−オン誘導体(1a−2)6.17g
(収率77%)を得た。 融点;100.5-101℃ MS(m/e):402(M++1),386,344 IR(KBr)cm-1:1770,17351 H-NMR δ(CDCl3):0.07(s,6H),0.88(s,9H),1.14(d,J=6.
3Hz,3H),1.26,1.28(2overlapping t,J=7.1Hz,6H),1.46
(s,3H),3.01(m,1H),4.15(d,J=2.2Hz,1H),4.21(m,3H),5.
98(broad s,1H)
60% sodium hydride 1.12 g (2
After adding 5 ml of hexane to 8.0 mmol) and stirring, hexane was removed by a gradient method. After washing by repeating this procedure several times, 20 ml of tetrahydrofuran was added, and diethyl methylmalonate (7
-2) A solution of 4.52 g (26.0 mmol) dissolved in 20 ml of tetrahydrofuran was added dropwise over 15 minutes. After further stirring for 30 minutes, 4-acetoxyazetidine-
2-one derivative (4-1) 5.74 g (20.0 mmol)
Was added dropwise to 20 ml of tetrahydrofuran over 10 minutes, and the reaction was continued at room temperature for 1 hour. To the reaction solution was added 25 ml of a saturated aqueous solution of ammonium chloride, and the mixture was stirred and separated, then, the obtained tetrahydrofuran layer was washed with saturated brine and dehydrated with anhydrous magnesium sulfate, and the solvent was distilled off to obtain crude crystals. Recrystallization was performed using hexane, and 6.17 g of a white crystalline azetidin-2-one derivative (1a-2) was obtained.
(Yield 77%) was obtained. Melting point; 100.5-101 ° C MS (m / e): 402 (M + +1), 386,344 IR (KBr) cm -1 : 1770,1735 1 H-NMR δ (CDCl 3 ): 0.07 (s, 6H), 0.88 (s, 9H), 1.14 (d, J = 6.
3Hz, 3H), 1.26,1.28 (2overlapping t, J = 7.1Hz, 6H), 1.46
(s, 3H), 3.01 (m, 1H), 4.15 (d, J = 2.2Hz, 1H), 4.21 (m, 3H), 5.
98 (broad s, 1H)

【0045】実施例3Example 3

【0046】[0046]

【化14】 [Chemical 14]

【0047】(式中、Phはフェニル基を示す。以下同
様) テトラヒドロフラン5mlに60%水素化ナトリウム0.
43g(10.8mmol)を懸濁させ、室温で撹拌しなが
ら、メチルマロン酸ジベンジル(7−3)3.13g
(10.5mmol)をテトラヒドロフラン3mlに溶解した
溶液を20分かけて滴下した。さらに、室温で30分間
撹拌した後、4−アセトキシアゼチジン−2−オン誘導
体(4−1)2.87g(10.0mmol)をテトラヒド
ロフラン5mlに溶解した溶液を15分かけて滴下し、室
温で1.5時間反応を続けた。反応液に飽和塩化アンモ
ニウム水溶液15mlを加え撹拌した後、酢酸エチル20
mlを用いて抽出を行った。得られた酢酸エチル層を水洗
した後、無水硫酸マグネシウムで脱水し、次いで濃縮を
行って油状物を得た。これをシリカゲルカラムクロマト
グラフィー(展開溶媒;ヘキサン:酢酸エチル=4:
1)により精製して、白色結晶のアゼチジン−2−オン
誘導体(1a−3)4.28g(収率82%)を得た。 融点:93-93.5 ℃ MS(m/e):526(M++1),510,468 IR(KBr)cm-1:1770,17351 H-NMR δ(CDCl3):0.06(s,6H),0.87(s,9H),1.09(d,J=6.
4Hz,3H),1.50(s,3H),3.03(m,1H),4.19(m,1H),4.20(d,J=
2.1Hz,1H),5.11(m,4H),5.89(broad s,1H),7.23(m,4H),
7.32(m,6H)
(In the formula, Ph represents a phenyl group. The same applies to the following.) 60 ml of 60% sodium hydride was added to 5 ml of tetrahydrofuran.
43 g (10.8 mmol) was suspended, and 3.13 g of dibenzyl methylmalonate (7-3) was stirred at room temperature.
A solution of (10.5 mmol) in 3 ml of tetrahydrofuran was added dropwise over 20 minutes. Furthermore, after stirring at room temperature for 30 minutes, a solution prepared by dissolving 2.87 g (10.0 mmol) of 4-acetoxyazetidin-2-one derivative (4-1) in 5 ml of tetrahydrofuran was added dropwise over 15 minutes, and at room temperature. The reaction was continued for 1.5 hours. After adding 15 ml of saturated aqueous ammonium chloride solution to the reaction mixture and stirring, ethyl acetate 20
Extraction was performed using ml. The obtained ethyl acetate layer was washed with water, dehydrated with anhydrous magnesium sulfate, and then concentrated to obtain an oily substance. This was subjected to silica gel column chromatography (developing solvent; hexane: ethyl acetate = 4:
Purification by 1) yielded 4.28 g (yield 82%) of white crystalline azetidin-2-one derivative (1a-3). Melting point: 93-93.5 ° C MS (m / e): 526 (M + +1), 510,468 IR (KBr) cm -1 : 1770,1735 1 H-NMR δ (CDCl 3 ): 0.06 (s, 6H), 0.87 (s, 9H), 1.09 (d, J = 6.
4Hz, 3H), 1.50 (s, 3H), 3.03 (m, 1H), 4.19 (m, 1H), 4.20 (d, J =
2.1Hz, 1H), 5.11 (m, 4H), 5.89 (broad s, 1H), 7.23 (m, 4H),
7.32 (m, 6H)

【0048】実施例4Example 4

【0049】[0049]

【化15】 [Chemical 15]

【0050】テトラヒドロフラン15mlに60%水素化
ナトリウム2.17g(54.3mmol)を懸濁させ、室
温で撹拌しながら、メチルマロン酸tert−ブチルエ
チル(7−4)10.9g(54.0mmol)をテトラヒ
ドロフラン20mlに溶解した溶液を1時間かけて滴下し
た。さらに、室温で30分間撹拌した後、4−アセトキ
シアゼチジン−2−オン誘導体(4−1)14.1g
(49.1mmol)をテトラヒドロフラン30mlに溶解し
た溶液を20分かけて滴下し、室温で一晩反応を続け
た。反応液に飽和塩化アンモニウム水溶液50mlを加え
撹拌した後、酢酸エチル50mlを用いて抽出を行った。
得られた酢酸エチル層を飽和食塩水25mlで2回洗浄し
た後、無水硫酸マグネシウムで脱水し、次いで濾過、濃
縮を行って粗生成物を得た。これをシリカゲルカラムク
ロマトグラフィー(展開溶媒;ヘキサン:酢酸エチル=
4:1)により精製して、白色結晶のアゼチジン−2−
オン誘導体(1a−4)及び(1a−5)の異性体混合
物〔混合比(1a−4):(1a−5)=77:23〕
14.2g(収率67%)を得た。 融点:73-74℃ MS(m/e):414,372 IR(KBr)cm-1:1765,17351 H-NMR δ(CDCl3):0.07(s,3H),0.08(s,3H),0.89(s,9H)
1.15(d,J=6.4Hz,3H×23/100),1.20(d,J=6.3Hz,3H×77/1
00),1.27(d,J=7.1Hz,3H×77/100),1.29(d,J=7.1Hz,3H×
23/100),1.41(s,3H×23/100),1.42(s,3H×77/100),1.45
(s,9H×23/100),1.47(s,9H×77/100),2.98(m,1H×23/10
0),3.02(m,1H×77/100),4.04(d,J=2.1Hz,1H×77/100),
4.09(d,J=2.2Hz,1H×23/100),4.20(m,3H),5.97(broad
s,1H)
2.17 g (54.3 mmol) of 60% sodium hydride was suspended in 15 ml of tetrahydrofuran, and 10.9 g (54.0 mmol) of tert-butylethyl methylmalonate (7-4) was stirred with stirring at room temperature. A solution dissolved in 20 ml of tetrahydrofuran was added dropwise over 1 hour. Furthermore, after stirring for 30 minutes at room temperature, 14.1 g of 4-acetoxyazetidin-2-one derivative (4-1)
A solution of (49.1 mmol) dissolved in 30 ml of tetrahydrofuran was added dropwise over 20 minutes, and the reaction was continued at room temperature overnight. After adding 50 ml of a saturated ammonium chloride aqueous solution to the reaction mixture and stirring, extraction was performed using 50 ml of ethyl acetate.
The obtained ethyl acetate layer was washed twice with 25 ml of saturated saline, dried over anhydrous magnesium sulfate, and then filtered and concentrated to obtain a crude product. This is subjected to silica gel column chromatography (developing solvent; hexane: ethyl acetate =
4: 1) to give white crystalline azetidine-2-
Isomeric mixture of on-derivatives (1a-4) and (1a-5) [mixing ratio (1a-4) :( 1a-5) = 77: 23]
14.2 g (yield 67%) was obtained. Melting point: 73-74 ° C MS (m / e): 414,372 IR (KBr) cm -1 : 1765,1735 1 H-NMR δ (CDCl 3 ): 0.07 (s, 3H), 0.08 (s, 3H), 0.89 (s, 9H)
1.15 (d, J = 6.4Hz, 3H × 23/100), 1.20 (d, J = 6.3Hz, 3H × 77/1
00), 1.27 (d, J = 7.1Hz, 3H × 77/100), 1.29 (d, J = 7.1Hz, 3H ×
23/100), 1.41 (s, 3H × 23/100), 1.42 (s, 3H × 77/100), 1.45
(s, 9H x 23/100), 1.47 (s, 9H x 77/100), 2.98 (m, 1H x 23/10
0), 3.02 (m, 1H × 77/100), 4.04 (d, J = 2.1Hz, 1H × 77/100),
4.09 (d, J = 2.2Hz, 1H × 23/100), 4.20 (m, 3H), 5.97 (broad
s, 1H)

【0051】実施例5Example 5

【0052】[0052]

【化16】 [Chemical 16]

【0053】60%水素化ナトリウム0.30g(7.
5mmol)にヘキサン3mlを加え撹拌した後、傾斜法によ
りヘキサンを除去した。これにテトラヒドロフラン3.
5mlを加え、室温で撹拌しながら、メチルマロン酸ジ−
(1)−メンチル(7−5)2.96g(7.5mmol)
をテトラヒドロフラン5mlに溶解した溶液を15分かけ
て滴下した。さらに、室温で30分間撹拌した後、4−
アセトキシアゼチジン−2−オン誘導体(4−1)2.
01g(7.0mmol)をテトラヒドロフラン5mlに溶解
した溶液を10分かけて滴下し、室温で1時間反応を続
けた。反応液に飽和塩化アンモニウム水溶液10mlを加
え撹拌、分液した後、テトラヒドロフラン層を飽和食塩
水で洗浄し、次いで無水硫酸マグネシウムで脱水し、溶
媒を留去して粗生成物を得た。これをシリカゲルカラム
クロマトグラフィー(展開溶媒;ヘキサン:酢酸エチル
=8:1)により精製して、無色油状のアゼチジン−2
−オン誘導体(1a−6)2.94g(収率68%)を
得た。 MS(m/e):622(M++1),564 IR(neat)cm-1:1770,1740,17201 H-NMR δ(CDCl3):0.07(s,3H),0.08(s,3H),0.72(d,J=7.
0Hz,3H),0.77(d,J=7.0Hz,3H),0.88(s,9H),0.91(d,J=6.7
Hz,6H),0.92(d,J=6.5Hz,6H),0.95(m,6H),1.22(d,J=6.3H
z,3H),1.42(m,4H),1.45(s,3H),1.70(m,4H),1.86(m,2H),
2.03(m,2H),3.10(m,1H),4.06(d,J=2.2Hz,1H),4.22(m,1
H),4.73(m,2H),5.91(s,1H)
0.30 g of 60% sodium hydride (7.
After adding 3 ml of hexane to 5 mmol) and stirring, hexane was removed by a gradient method. Tetrahydrofuran 3.
Add 5 ml and stir at room temperature while stirring with methylmalonic acid di-
2.96 g (7.5 mmol) of (1) -menthyl (7-5)
Was dissolved in 5 ml of tetrahydrofuran and added dropwise over 15 minutes. Further, after stirring at room temperature for 30 minutes, 4-
Acetoxyazetidin-2-one derivative (4-1) 2.
A solution prepared by dissolving 01 g (7.0 mmol) in 5 ml of tetrahydrofuran was added dropwise over 10 minutes, and the reaction was continued at room temperature for 1 hour. After adding 10 ml of a saturated ammonium chloride aqueous solution to the reaction solution, stirring and separating the layers, the tetrahydrofuran layer was washed with saturated saline and then dried over anhydrous magnesium sulfate, and the solvent was distilled off to obtain a crude product. This was purified by silica gel column chromatography (developing solvent; hexane: ethyl acetate = 8: 1) to give colorless oily azetidine-2.
2.94 g (yield 68%) of the -one derivative (1a-6) was obtained. MS (m / e): 622 (M + +1), 564 IR (neat) cm -1 : 1770,1740,1720 1 H-NMR δ (CDCl 3 ): 0.07 (s, 3H), 0.08 (s, 3H), 0.72 (d, J = 7.
0Hz, 3H), 0.77 (d, J = 7.0Hz, 3H), 0.88 (s, 9H), 0.91 (d, J = 6.7
Hz, 6H), 0.92 (d, J = 6.5Hz, 6H), 0.95 (m, 6H), 1.22 (d, J = 6.3H
z, 3H), 1.42 (m, 4H), 1.45 (s, 3H), 1.70 (m, 4H), 1.86 (m, 2H),
2.03 (m, 2H), 3.10 (m, 1H), 4.06 (d, J = 2.2Hz, 1H), 4.22 (m, 1
H), 4.73 (m, 2H), 5.91 (s, 1H)

【0054】実施例6Example 6

【0055】[0055]

【化17】 [Chemical 17]

【0056】テトラヒドロフラン50mlに60%水素化
ナトリウム2.92g(73.0mmol)を懸濁させ、室
温で攪拌しながら、n−プロピルマロン酸ジアリル(7
−6)33.07g(73.0mmol)をテトラヒドロフ
ラン50mlに溶解した溶液を滴下した。2.5時間攪拌
した後、4−アセトキシアゼチジン−2−オン誘導体
(4−1)20.10g(70.0mmol)をテトラヒド
ロフラン50mlに溶解した溶液を30分かけて滴下し、
室温で15時間反応を続けた。反応液に飽和塩化アンモ
ニウム水溶液60mlを加え攪拌、分液した後、得られた
テトラヒドロフラン層を飽和食塩水で洗浄、無水硫酸マ
グネシウムで脱水し、溶媒を留去して粗生成物を得た。
これをシリカゲルカラムクロマトグラフィー(展開溶
媒;ヘキサン:酢酸エチル=10:1)により精製し
て、白色結晶のアゼチジン−2−オン誘導体(1a−
7)26.32g(収率83%)を得た。 融点:47-48℃ MS(m/e):438,396 IR(KBr)cm-1:1770,17301 H-NMR δ(CDCl3):0.07(s,6H),0.88(s,9H),0.94(t,J=7.
3Hz,3H),1.17(d,J=6.4Hz,3H),1.25(m,1H),1.47(m,1H),
1.80(ddd,J=4.4,12.5,14.0Hz,1H) 1.97(ddd,J=4.6,12.7,14.0Hz,1H),3.08(m,1H),4.25(m,2
H),4.65(m,4H),5.30(m,4H),5.88(m,3H)
2.92 g (73.0 mmol) of 60% sodium hydride was suspended in 50 ml of tetrahydrofuran, and diallyl n-propylmalonate (7
-6) A solution prepared by dissolving 33.07 g (73.0 mmol) in 50 ml of tetrahydrofuran was added dropwise. After stirring for 2.5 hours, a solution of 20.10 g (70.0 mmol) of 4-acetoxyazetidin-2-one derivative (4-1) in 50 ml of tetrahydrofuran was added dropwise over 30 minutes,
The reaction was continued at room temperature for 15 hours. After adding 60 ml of a saturated aqueous solution of ammonium chloride to the reaction solution, stirring and separating the layers, the obtained tetrahydrofuran layer was washed with saturated brine and dehydrated with anhydrous magnesium sulfate, and the solvent was distilled off to obtain a crude product.
This was purified by silica gel column chromatography (developing solvent; hexane: ethyl acetate = 10: 1) to give a white crystalline azetidin-2-one derivative (1a-).
7) 26.32 g (yield 83%) was obtained. Melting point: 47-48 ° C MS (m / e): 438,396 IR (KBr) cm -1 : 1770,1730 1 H-NMR δ (CDCl 3 ): 0.07 (s, 6H), 0.88 (s, 9H), 0.94 (t, J = 7.
3Hz, 3H), 1.17 (d, J = 6.4Hz, 3H), 1.25 (m, 1H), 1.47 (m, 1H),
1.80 (ddd, J = 4.4,12.5,14.0Hz, 1H) 1.97 (ddd, J = 4.6,12.7,14.0Hz, 1H), 3.08 (m, 1H), 4.25 (m, 2
H), 4.65 (m, 4H), 5.30 (m, 4H), 5.88 (m, 3H)

【0057】実施例7Example 7

【0058】[0058]

【化18】 [Chemical 18]

【0059】N,N−ジメチルホルムアミド20mlに実
施例1で得られたアゼチジン−2−オン誘導体(1a−
1)8.50g(20.0mmol)及びtert−ブチル
ジメチルシリルクロライド6.04g(40.0mmol)
を溶解し、トリエチルアミン6.06g(60.0mmo
l)をN,N−ジメチルホルムアミド5mlに溶解した溶
液を室温で15分かけて滴下した。さらに4時間撹拌し
た後、4−N,N−ジメチルアミノピリジン0.12g
(1.1mmol)を加えて室温で6日間反応させた。反応
液を減圧濃縮した後、水40mlを加えジエチルエーテル
200mlを用いて抽出を行った。得られたジエチルエー
テル層を飽和食塩水30mlで洗浄した後、無水硫酸マグ
ネシウムで脱水し、次いで溶媒を留去して粗生成物を得
た。これをアルミナカムラクロマトグラフィー(展開溶
媒;ヘキサン:酢酸エチル=9:1〜8:2)により精
製して、無色油状のアゼチジン−2−オン誘導体(1b
−1)8.02g(収率74%)を得た。 MS(m/e):540(M++1),524,482 IR(neat)cm-1:1760,17401 H-NMR δ(CDCl3):0.07(s,3H),0.08(s,3H),0.11(s,3H),
0.29(s,3H),0.89(s,9H),0.96(s,9H),1.22(d,J=6.2Hz,3
H),1.50(s,3H),3.07(dd,J=2.6,6.8Hz,1H),4.09(m,1H),
4.35(d,J=2.6Hz,1H),4.64(m,4H),5.30(m,4H),5.90(m,2
H)
20 ml of N, N-dimethylformamide was added to the azetidin-2-one derivative (1a-) obtained in Example 1.
1) 8.50 g (20.0 mmol) and tert-butyldimethylsilyl chloride 6.04 g (40.0 mmol)
Was dissolved, and 6.06 g (60.0 mmo of triethylamine was dissolved.
A solution obtained by dissolving l) in 5 ml of N, N-dimethylformamide was added dropwise at room temperature over 15 minutes. After further stirring for 4 hours, 0.12 g of 4-N, N-dimethylaminopyridine
(1.1 mmol) was added and reacted at room temperature for 6 days. The reaction solution was concentrated under reduced pressure, 40 ml of water was added, and the mixture was extracted with 200 ml of diethyl ether. The obtained diethyl ether layer was washed with 30 ml of saturated saline and then dried over anhydrous magnesium sulfate, and then the solvent was distilled off to obtain a crude product. This was purified by alumina kamura chromatography (developing solvent; hexane: ethyl acetate = 9: 1 to 8: 2) to give a colorless oily azetidin-2-one derivative (1b
-1) 8.02 g (yield 74%) was obtained. MS (m / e): 540 (M + +1), 524,482 IR (neat) cm -1 : 1760,1740 1 H-NMR δ (CDCl 3 ): 0.07 (s, 3H), 0.08 (s, 3H) , 0.11 (s, 3H),
0.29 (s, 3H), 0.89 (s, 9H), 0.96 (s, 9H), 1.22 (d, J = 6.2Hz, 3
H), 1.50 (s, 3H), 3.07 (dd, J = 2.6,6.8Hz, 1H), 4.09 (m, 1H),
4.35 (d, J = 2.6Hz, 1H), 4.64 (m, 4H), 5.30 (m, 4H), 5.90 (m, 2
H)

【0060】実施例8Example 8

【0061】[0061]

【化19】 [Chemical 19]

【0062】N,N−ジメチルホルムアミド13mlに実
施例1で得られたアゼチジン−2−オン誘導体(1a−
1)1.70g(4.0mmol)及びメチルジフェニルシ
リルクロライド1.12g(4.8mmol)を溶解し、氷
浴中で撹拌した。これに、トリエチルアミン0.48g
(4.8mmol)をN,N−ジメチルホルムアミド2mlに
溶解した溶液を40分かけて滴下し、冷蔵庫中で一晩放
置した。反応液を減圧下で溶媒留去した後、水10mlと
酢酸エチル15mlを加え抽出した。得られた酢酸エチル
層を無水硫酸マグネシウムで脱水した後、溶媒を留去し
て油状物を得た。これをシリカゲルカラムクロマトグラ
フィー(展開溶媒;ヘキサン:酢酸エチル=5:1)に
より精製して、無色油状のアゼチジン−2−オン誘導体
(1b−2)1.69g(収率68%)を得た。 MS(m/e):606,564,544 IR(neat)cm-1:1755,17351 H-NMR δ(CDCl3):-0.02(s,3H),0.06(s,3H),0.82(s,3
H),0.88(s,9H),1.14(d,J=6.3Hz,3H),1.25(s,3H),3.15
(m,1H),4.16(m,1H),4.32(m,4H),4.43(d,J=2.7Hz,1H),5.
18(m,4H),5.71(m,2H),7.47(m,10H)
The azetidin-2-one derivative (1a-obtained in Example 1) was added to 13 ml of N, N-dimethylformamide.
1) 1.70 g (4.0 mmol) and 1.12 g (4.8 mmol) of methyldiphenylsilyl chloride were dissolved and stirred in an ice bath. 0.48g of triethylamine
A solution of (4.8 mmol) dissolved in 2 ml of N, N-dimethylformamide was added dropwise over 40 minutes and left overnight in the refrigerator. The solvent of the reaction solution was distilled off under reduced pressure, and then 10 ml of water and 15 ml of ethyl acetate were added for extraction. The obtained ethyl acetate layer was dehydrated with anhydrous magnesium sulfate, and then the solvent was distilled off to obtain an oily substance. This was purified by silica gel column chromatography (developing solvent; hexane: ethyl acetate = 5: 1) to obtain 1.69 g (yield 68%) of a colorless oily azetidin-2-one derivative (1b-2). .. MS (m / e): 606,564,544 IR (neat) cm -1 : 1755,1735 1 H-NMR δ (CDCl 3 ):-0.02 (s, 3H), 0.06 (s, 3H), 0.82 (s, 3
H), 0.88 (s, 9H), 1.14 (d, J = 6.3Hz, 3H), 1.25 (s, 3H), 3.15
(m, 1H), 4.16 (m, 1H), 4.32 (m, 4H), 4.43 (d, J = 2.7Hz, 1H), 5.
18 (m, 4H), 5.71 (m, 2H), 7.47 (m, 10H)

【0063】実施例9Example 9

【0064】[0064]

【化20】 [Chemical 20]

【0065】N,N−ジメチルホルムアミド25mlに実
施例1で得られたアゼチジン−2−オン誘導体(1a−
1)2.87g(6.7mmol)及びトリエチルシリルク
ロライド1.58g(10.5mmol)を溶解し、氷浴中
で撹拌した。これに、トリエチルアミン1.06g(1
0.5mmol)をN,N−ジメチルホルムアミド5mlに溶
解した溶液を20分かけて滴下し、冷蔵庫中で一晩放置
した。反応液を減圧下で溶媒留去した後、飽和炭酸水素
ナトリウム水溶液15mlと酢酸エチル25mlを加え抽出
した。得られた酢酸エチル層を無水硫酸マグネシウムで
脱水した後、溶媒を留去して油状物を得た。これをアル
ミナカラムクロマトグラフィー(展開溶媒;ヘキサン:
酢酸エチル=10:1)により精製して、無色油状のア
ゼチジン−2−オン誘導体(1b−3)2.20g(収
率61%)を得た。 MS(m/e):524,511,482 IR(neat)cm-1:17501 H-NMR δ(CDCl3):0.06(s,3H),0.07(s,3H),0.78(m,6H),
0.88(s,9H),0.98(t,J=7.8Hz,9H),1.26(d,J=6.3Hz,3H),
1.49(s,3H),3.05(m,1H),4.12(m,1H),4.21(d,J=2.6Hz,1
H),4.63(m,4H),5.30(m,4H),5.87(m,2H)
25 ml of N, N-dimethylformamide was added to the azetidin-2-one derivative (1a-) obtained in Example 1.
1) 2.87 g (6.7 mmol) and 1.58 g (10.5 mmol) of triethylsilyl chloride were dissolved and stirred in an ice bath. To this, 1.06 g of triethylamine (1
A solution of 0.5 mmol) dissolved in 5 ml of N, N-dimethylformamide was added dropwise over 20 minutes, and the mixture was left overnight in the refrigerator. The solvent was distilled off from the reaction solution under reduced pressure, and then 15 ml of a saturated aqueous sodium hydrogen carbonate solution and 25 ml of ethyl acetate were added for extraction. The obtained ethyl acetate layer was dehydrated with anhydrous magnesium sulfate, and then the solvent was distilled off to obtain an oily substance. Alumina column chromatography (developing solvent; hexane:
Purification by ethyl acetate = 10: 1) gave 2.20 g (yield 61%) of colorless oily azetidin-2-one derivative (1b-3). MS (m / e): 524,511,482 IR (neat) cm -1 : 1750 1 H-NMR δ (CDCl 3 ): 0.06 (s, 3H), 0.07 (s, 3H), 0.78 (m, 6H),
0.88 (s, 9H), 0.98 (t, J = 7.8Hz, 9H), 1.26 (d, J = 6.3Hz, 3H),
1.49 (s, 3H), 3.05 (m, 1H), 4.12 (m, 1H), 4.21 (d, J = 2.6Hz, 1
H), 4.63 (m, 4H), 5.30 (m, 4H), 5.87 (m, 2H)

【0066】実施例10Example 10

【0067】[0067]

【化21】 [Chemical 21]

【0068】N,N−ジメチルホルムアミド5mlに60
%水素化ナトリウム0.19g(4.8mmol)を懸濁さ
せ、0℃に冷却し、実施例1で得られたアゼチジン−2
−オン誘導体(1a−1)1.93g(4.5mmol)を
N,N−ジメチルホルムアミド5mlに溶解した溶液を1
0分かけて滴下した。さらに、30分間撹拌した後、室
温に戻し、塩化ベンジル0.58g(4.6mmol)を滴
下し、4時間反応を続けた。反応液に飽和塩化アンモニ
ウム水溶液5mlを加え、ジエチルエーテル50mlで抽出
した。得られたジエチルエーテル層を無水硫酸マグネシ
ウムで脱水した後、溶媒を留去して粗生成物を得た。こ
れをシリカゲルカラムクロマトグラフィー(展開溶媒;
ヘキサン:酢酸エチル=4:1)により精製して、無色
油状のアゼチジン−2−オン誘導体(1b−4)1.5
7g(収率68%)を得た。 MS(m/e):516(M++1),500,458 IR(neat)cm-1:1760,17401 H-NMR δ(CDCl3):-0.01(s,3H),0.05(s,3H),0.85(s,9
H),1.13(d,J=6.3Hz,3H),1.31(s,3H),2.99(m,1H),4.18
(m,1H),4.23(d,J=15.4Hz,1H),4.31(d,J=2.1Hz,1H),4.57
(m,5H),5.28(m,4H),5.83(m,2H),7.31(m,5H)
60 ml of 5 ml of N, N-dimethylformamide
0.19 g (4.8 mmol) of sodium hydride was suspended and cooled to 0 ° C. to obtain azetidine-2 obtained in Example 1.
A solution prepared by dissolving 1.93 g (4.5 mmol) of the -one derivative (1a-1) in 5 ml of N, N-dimethylformamide was prepared.
It was added dropwise over 0 minutes. After stirring for 30 minutes, the temperature was returned to room temperature, 0.58 g (4.6 mmol) of benzyl chloride was added dropwise, and the reaction was continued for 4 hours. 5 ml of a saturated aqueous solution of ammonium chloride was added to the reaction solution, and the mixture was extracted with 50 ml of diethyl ether. The obtained diethyl ether layer was dehydrated with anhydrous magnesium sulfate, and then the solvent was distilled off to obtain a crude product. This is subjected to silica gel column chromatography (developing solvent;
Hexane: ethyl acetate = 4: 1) to give a colorless oily azetidin-2-one derivative (1b-4) 1.5.
7 g (yield 68%) was obtained. MS (m / e): 516 (M + +1), 500,458 IR (neat) cm -1 : 1760,1740 1 H-NMR δ (CDCl 3 ):-0.01 (s, 3H), 0.05 (s, 3H ), 0.85 (s, 9
H), 1.13 (d, J = 6.3Hz, 3H), 1.31 (s, 3H), 2.99 (m, 1H), 4.18
(m, 1H), 4.23 (d, J = 15.4Hz, 1H), 4.31 (d, J = 2.1Hz, 1H), 4.57
(m, 5H), 5.28 (m, 4H), 5.83 (m, 2H), 7.31 (m, 5H)

【0069】実施例11Example 11

【0070】[0070]

【化22】 [Chemical formula 22]

【0071】実施例1で得られたアゼチジン−2−オン
誘導体(1a−1)2.13g(5.0mmol)、60%
水素化ナトリウム0.22g(5.5mmol)及び臭化p
−tert−ブチルベンジル1.25g(5.5mmol)
を用いて、前記実施例10に従ってN−ベンジル化を行
い、無色油状のアゼチジン−2−オン誘導体(1b−
5)2.27g(収率79%)を得た。 MS(m/e):556,514 IR(neat)cm-1:1765,17401 H-NMR δ(CDCl3):-0.06(s,3H),0.03(s,3H),0.84(s,9
H),1.13(d,J=6.3Hz,3H),1.29(s,9H),1.33(s,3H),2.98(d
d,J=2.1,4.5Hz,1H),4.13(d,J=15.3Hz,1H),4.14(m,1H),
4.35(d,J=2.1Hz,1H),4.52(m,5H),5.27(m,4H),5.80(m,4
H),7.29(m,4H)
2.13 g (5.0 mmol) of the azetidin-2-one derivative (1a-1) obtained in Example 1, 60%
0.22 g (5.5 mmol) of sodium hydride and p-bromide
-Tert-butylbenzyl 1.25 g (5.5 mmol)
Was subjected to N-benzylation according to Example 10 above to give a colorless oily azetidin-2-one derivative (1b-
5) 2.27 g (yield 79%) was obtained. MS (m / e): 556,514 IR (neat) cm -1 : 1765,1740 1 H-NMR δ (CDCl 3 ):-0.06 (s, 3H), 0.03 (s, 3H), 0.84 (s, 9
H), 1.13 (d, J = 6.3Hz, 3H), 1.29 (s, 9H), 1.33 (s, 3H), 2.98 (d
d, J = 2.1,4.5Hz, 1H), 4.13 (d, J = 15.3Hz, 1H), 4.14 (m, 1H),
4.35 (d, J = 2.1Hz, 1H), 4.52 (m, 5H), 5.27 (m, 4H), 5.80 (m, 4
H), 7.29 (m, 4H)

【0072】実施例12Example 12

【0073】[0073]

【化23】 [Chemical formula 23]

【0074】実施例1で得られたアゼチジン−2−オン
誘導体(1a−1)2.13g(5.0mmol)、60%
水素化ナトリウム0.24g(6.0mmol)及び塩化p
−メトキシベンジル0.94g(6.0mmol)を用い
て、前記実施例10に従ってN−ベンジル化を行い、無
色油状のアゼチジン−2−オン誘導体(1b−6)2.
07g(収率76%)を得た。 MS(m/e):488 IR(neat)cm-1:1760,17351 H-NMR δ(CDCl3):0.01(s,3H),0.05(s,3H),0.85(s,9H),
1.13(d,J=6.3Hz,3H),1.30(s,3H),2.98(dd,J=2.1,4.3Hz,
1H),3.79(s,3H),4.16(m,1H),4.18(d,J=15.2Hz,1H),4.37
(d,J=2.1Hz,1H),4.43(d,J=15.2Hz,1H),4.59(m,4H),5.28
(m,4H),5.82(m,2H),6.83(dd,J=2.1,6.3Hz,2H),7.27(dd,
J=2.1,6.3Hz,2H)
2.13 g (5.0 mmol) of the azetidin-2-one derivative (1a-1) obtained in Example 1, 60%
0.24 g (6.0 mmol) of sodium hydride and p chloride
N-benzylation was carried out according to Example 10 above using 0.94 g (6.0 mmol) of -methoxybenzyl to give a colorless oily azetidin-2-one derivative (1b-6) .2.
07 g (yield 76%) was obtained. MS (m / e): 488 IR (neat) cm -1 : 1760,1735 1 H-NMR δ (CDCl 3 ): 0.01 (s, 3H), 0.05 (s, 3H), 0.85 (s, 9H),
1.13 (d, J = 6.3Hz, 3H), 1.30 (s, 3H), 2.98 (dd, J = 2.1,4.3Hz,
1H), 3.79 (s, 3H), 4.16 (m, 1H), 4.18 (d, J = 15.2Hz, 1H), 4.37
(d, J = 2.1Hz, 1H), 4.43 (d, J = 15.2Hz, 1H), 4.59 (m, 4H), 5.28
(m, 4H), 5.82 (m, 2H), 6.83 (dd, J = 2.1,6.3Hz, 2H), 7.27 (dd,
(J = 2.1, 6.3Hz, 2H)

【0075】実施例13Example 13

【0076】[0076]

【化24】 [Chemical formula 24]

【0077】実施例1で得られたアゼチジン−2−オン
誘導体(1a−2)4.01g(10.0mmol)、60
%水素化ナトリウム0.40g(11.0mmol)及び塩
化ベンジル1.39g(6.0mmol)を用いて、前記実
施例10に従ってN−ベンジル化を行い、無色油状のア
ゼチジン−2−オン誘導体(1b−7)4.30g(収
率88%)を得た。 MS(m/e):476,434 IR(neat)cm-1:1760,17301 H-NMR δ(CDCl3):0.00(s,3H),0.06(s,3H),0.87(s,9H),
1.16(d,J=6.3Hz,3H),1.20,1.22(2overlapping t,J=7.3H
z,6H),1.30(s,3H),2.99(dd,J=2.1,4.5Hz,1H),4.17(m,6
H),4.36(d,J=2.1Hz,1H),4.55(d,J=15.3Hz,1H),7.31(m,5
H)
4.01 g (10.0 mmol) of the azetidin-2-one derivative (1a-2) obtained in Example 1, 60
% Sodium hydride 0.40 g (11.0 mmol) and benzyl chloride 1.39 g (6.0 mmol) were used for N-benzylation according to the above-mentioned Example 10, and colorless oily azetidin-2-one derivative (1b). -7) 4.30 g (yield 88%) was obtained. MS (m / e): 476,434 IR (neat) cm -1 : 1760,1730 1 H-NMR δ (CDCl 3 ): 0.00 (s, 3H), 0.06 (s, 3H), 0.87 (s, 9H),
1.16 (d, J = 6.3Hz, 3H), 1.20,1.22 (2overlapping t, J = 7.3H
z, 6H), 1.30 (s, 3H), 2.99 (dd, J = 2.1,4.5Hz, 1H), 4.17 (m, 6
H), 4.36 (d, J = 2.1Hz, 1H), 4.55 (d, J = 15.3Hz, 1H), 7.31 (m, 5
H)

【0078】実施例14Example 14

【0079】[0079]

【化25】 [Chemical 25]

【0080】60%水素化ナトリウム0.40g(1
0.0mmol)にヘキサン5mlを加え撹拌した後、傾斜法
によりヘキサンを除去した。これにN,N−ジメチルホ
ルムアミド25mlを加えた後、実施例3で得られたアゼ
チジン−2−オン誘導体(1a−3)4.65g(8.
9mmol)を室温で加えた。さらに、室温で30分間撹拌
した後、塩化ベンジル1.12g(8.9mmol)をN,
N−ジメチルホルムアミド4mlに溶解した溶液を5分か
けて滴下し、室温で一晩撹拌を続けた。反応液を減圧下
で溶媒留去した後、飽和炭酸水素ナトリウム水溶液15
mlと酢酸エチル35mlを加え抽出した。得られた酢酸エ
チル層を無水硫酸マグネシウムで脱水した後、溶媒を留
去して油状物を得た。これをシリカゲルカラムクロマト
グラフィー(展開溶媒;ヘキサン:酢酸エチル=2:
1)により精製して、無色油状のアゼチジン−2−オン
誘導体(1b−8)3.50g(収率64%)を得た。 MS(m/e):600,558 IR(neat)cm-1:1760,17301 H-NMR δ(CDCl3):-0.03(s,3H),0.03(s,3H),0.84(s,9
H),1.10(d,J=6.3Hz,3H),1.30(s,3H),3.00(dd,J=2.1,4.4
Hz,1H),4.12(d,J=15.4Hz,1H),4.15(m,1H),4.37(d,J=15.
4Hz,1H),4.40(d,J=2.1Hz,1H),4.94(d,J=12.2Hz,1H),5.0
6(m,3H),7.26(m,15H)
60% sodium hydride 0.40 g (1
After adding 5 ml of hexane to 0.0 mmol) and stirring, hexane was removed by a gradient method. After adding 25 ml of N, N-dimethylformamide thereto, 4.65 g (8.A) of the azetidin-2-one derivative (1a-3) obtained in Example 3 was obtained.
9 mmol) was added at room temperature. Furthermore, after stirring at room temperature for 30 minutes, 1.12 g (8.9 mmol) of benzyl chloride was added to N,
A solution of 4 ml of N-dimethylformamide was added dropwise over 5 minutes and stirring was continued overnight at room temperature. After distilling off the solvent from the reaction solution under reduced pressure, a saturated aqueous solution of sodium hydrogen carbonate 15
ml and 35 ml of ethyl acetate were added for extraction. The obtained ethyl acetate layer was dehydrated with anhydrous magnesium sulfate, and then the solvent was distilled off to obtain an oily substance. This was subjected to silica gel column chromatography (developing solvent; hexane: ethyl acetate = 2:
Purification by 1) yielded 3.50 g (yield 64%) of azetidin-2-one derivative (1b-8) as a colorless oil. MS (m / e): 600,558 IR (neat) cm -1 : 1760,1730 1 H-NMR δ (CDCl 3 ):-0.03 (s, 3H), 0.03 (s, 3H), 0.84 (s, 9
H), 1.10 (d, J = 6.3Hz, 3H), 1.30 (s, 3H), 3.00 (dd, J = 2.1,4.4
Hz, 1H), 4.12 (d, J = 15.4Hz, 1H), 4.15 (m, 1H), 4.37 (d, J = 15.
4Hz, 1H), 4.40 (d, J = 2.1Hz, 1H), 4.94 (d, J = 12.2Hz, 1H), 5.0
6 (m, 3H), 7.26 (m, 15H)

【0081】参考例1Reference Example 1

【0082】[0082]

【化26】 [Chemical formula 26]

【0083】アルゴン気流下、酢酸パラジウム4.8mg
(0.02mmol)を1,4−ジオキサン2mlに懸濁さ
せ、これにトリフェニルホスフィン52.0mg(0.2
mmol)を1,4−ジオキサン2mlに溶解した溶液を滴下
した後、加熱還流し、さらに実施例1で得られたアゼチ
ジン−2−オン誘導体(1a−1)0.85g(2.0
mmol)、ギ酸0.37g(7.9mmol)及びトリエチル
アミン0.81g(8.0mmol)を1,4−ジオキサン
6mlに溶解した溶液を滴下し、3時間反応させた。反応
液に5%水酸化ナトリウム水溶液10ml及び酢酸エチル
10mlを加えて分液し、水層を1N塩酸で酸性にした
後、酢酸エチル20mlで抽出した。得られた酢酸エチル
層を無水硫酸マグネシウムで脱水した後、溶媒を留去し
て、白色結晶の目的化合物4−(1−カルボキシエチ
ル)−アゼチジン−2−オン誘導体(3−1)0.47
g(収率78%)を得た。なお、得られた化合物(3−
1)の式中波線のメチル基がα位である化合物(3α−
1)とβ位である化合物(3β−1)の生成比はα:β
=85:15であり、これらは高速液体クロマトグラフ
ィー(HPLC)(カラム;Inertsil OD
S、ジーエルサイエンス株式会社製、展開溶媒;アセト
ニトリル:水:酢酸=700:300:3)で分離し、
構造を決定した。 α体(3α−1) 融点:168-170℃ MS(m/e):286,244 IR(KBr)cm-1:17201 H-NMR δ(CDCl3):0.07(s,3H),0.08(s,3H),0.88(s,9H),
1.25(2overlapping d,J=6.2,7.3Hz,6H),2.56(qd,J=7.3,
9.8Hz,1H),2.80(dd,J=2.0,5.3Hz,1H),3.70(dd,J=2.0,9.
8Hz,1H),4.19(m,1H),6.67(broad s,1H) β体(3β−1) 融点:143.5-144.5℃ MS(m/e):286,244 IR(KBr)cm-1:17201 H-NMR δ(CDCl3):0.07(s,3H),0.08(s,3H),0.87(s,9H),
1.20(d,J=6.3Hz,3H),1.27(d,J=7.0Hz,3H),2.75(qd,J=5.
0,7.0Hz,1H),3.03(dd,J=2.2,4.3Hz,1H),3.94(dd,J=2.2,
5.0Hz,1H),4.20(qd,J=4.5,6.3Hz,1H),6.25(broad s,1H)
4.8 mg of palladium acetate under a stream of argon
(0.02 mmol) was suspended in 2 ml of 1,4-dioxane, and 52.0 mg (0.2
A solution of 2 mmol of 1,4-dioxane dissolved in 1,4-dioxane was added dropwise, followed by heating under reflux, and 0.85 g (2.0%) of the azetidin-2-one derivative (1a-1) obtained in Example 1.
mmol), 0.37 g (7.9 mmol) of formic acid and 0.81 g (8.0 mmol) of triethylamine dissolved in 6 ml of 1,4-dioxane were added dropwise and reacted for 3 hours. To the reaction mixture were added 5% aqueous sodium hydroxide solution (10 ml) and ethyl acetate (10 ml) for liquid separation. The aqueous layer was acidified with 1N hydrochloric acid and then extracted with 20 ml of ethyl acetate. The obtained ethyl acetate layer was dehydrated with anhydrous magnesium sulfate, and then the solvent was distilled off to give the target compound 4- (1-carboxyethyl) -azetidin-2-one derivative (3-1) 0.47 as white crystals.
g (yield 78%) was obtained. The obtained compound (3-
The compound (3α- in which the methyl group of the wavy line in the formula 1) is in the α-position
1) and the compound (3β-1) at the β-position have a production ratio of α: β
= 85:15, these are high performance liquid chromatography (HPLC) (column; Inertsil OD).
S, manufactured by GL Sciences Inc., developing solvent; acetonitrile: water: acetic acid = 700: 300: 3), and
The structure was determined. α-form (3α-1) Melting point: 168-170 ° C MS (m / e): 286,244 IR (KBr) cm -1 : 1720 1 H-NMR δ (CDCl 3 ): 0.07 (s, 3H), 0.08 (s , 3H), 0.88 (s, 9H),
1.25 (2overlapping d, J = 6.2,7.3Hz, 6H), 2.56 (qd, J = 7.3,
9.8Hz, 1H), 2.80 (dd, J = 2.0,5.3Hz, 1H), 3.70 (dd, J = 2.0,9.
8Hz, 1H), 4.19 (m, 1H), 6.67 (broad s, 1H) β-body (3β-1) Melting point: 143.5-144.5 ° C MS (m / e): 286,244 IR (KBr) cm -1 : 1720 1 H-NMR δ (CDCl 3 ): 0.07 (s, 3H), 0.08 (s, 3H), 0.87 (s, 9H),
1.20 (d, J = 6.3Hz, 3H), 1.27 (d, J = 7.0Hz, 3H), 2.75 (qd, J = 5.
0,7.0Hz, 1H), 3.03 (dd, J = 2.2,4.3Hz, 1H), 3.94 (dd, J = 2.2,
5.0Hz, 1H), 4.20 (qd, J = 4.5,6.3Hz, 1H), 6.25 (broad s, 1H)

【0084】参考例2Reference Example 2

【0085】[0085]

【化27】 [Chemical 27]

【0086】窒素雰囲気下、酢酸パラジウム9.0mg
(0.04mmol)及びトリフェニルホスフィン53.0
mg(0.20mmol)を1,4−ジオキサン8mlに溶解し
た溶液に、ギ酸746.0mg(16.22mmol)及びト
リエチルアミン1647.7mg(16.31mmol)を
1,4−ジオキサン10mlに溶解した溶液を加え、加熱
還流した。これに実施例6で得られたアゼチジン−2−
オン誘導体(1a−7)1815.4mg(4.01mmo
l)を1,4−ジオキサン5mlに溶解した溶液を40分
かけて滴下し、さらに5時間加熱還流を続けた。反応液
を室温まで冷却し、ジエチルエーテル15mlと5%水酸
化ナトリウム水溶液20mlで抽出した後、アルカリ層に
2N塩酸を加えてpH2とし、酢酸エチル35mlで2回抽
出を行った。得られた酢酸エチル層を飽和食塩水で洗浄
後、無水硫酸マグネシウムで脱水、次いで濾過、濃縮を
行って、白色結晶の目的化合物4−(1−カルボキシブ
チル)−アゼチジン−2−オン誘導体(3−2)98
5.8mg(収率75%)を得た。なお、得られた化合物
(3−2)の式中波線のn−プロピル基がα位である化
合物(3α−2)とβ位である化合物(3β−2)の生
成比はα:β=73:27であり、これらはHPLC
(カラム及び展開溶媒の条件は参考例1と同じ)で分離
し、構造を決定した。 α体(3α−2) 融点:173-174℃ MS(m/e):314,272 IR(KBr)cm-1:17201 H-NMR δ(CD3OD):0.08(s,3H),0.10(s,3H),0.90(s,9H),
0.94(t,J=7.2Hz,3H),1.23(d,J=6.3Hz,3H),1.40(m,2H),
1.60(m,2H),2.47(m,1H),2.88(dd,J=2.0,4.3Hz,1H),3.78
(dd,J=2.0,8.7Hz,1H),4.20(qd,J=4.3,6.3Hz,1H) β体(3β−2) 融点:164.5-166℃ MS(m/e):314,272 IR(KBr)cm-1:17201 H-NMR δ(CD3OD):0.07(s,3H),0.08(s,3H),0.89(s,9H),
0.95(t,J=7.2Hz,3H),1.16(d,J=6.4Hz,3H),1.45(m,3H),
1.64(m,1H),2.48(m,1H),3.01(dd,J=2.0,2.7Hz,1H),3.77
(dd,J=2.0,8.4Hz,1H),4.22(qd,J=2.7,6.4Hz,1H)
9.0 mg of palladium acetate under nitrogen atmosphere
(0.04 mmol) and triphenylphosphine 53.0
To a solution prepared by dissolving mg (0.20 mmol) in 8 ml of 1,4-dioxane, a solution prepared by dissolving 746.0 mg (16.22 mmol) of formic acid and 1647.7 mg (16.31 mmol) of triethylamine in 10 ml of 1,4-dioxane was added. In addition, the mixture was heated to reflux. The azetidine-2-obtained in Example 6 was added to this.
On-derivative (1a-7) 1815.4 mg (4.01 mmo)
A solution prepared by dissolving l) in 5 ml of 1,4-dioxane was added dropwise over 40 minutes, and the mixture was heated under reflux for another 5 hours. The reaction mixture was cooled to room temperature, extracted with 15 ml of diethyl ether and 20 ml of 5% aqueous sodium hydroxide solution, the alkaline layer was adjusted to pH 2 with 2N hydrochloric acid, and extracted twice with 35 ml of ethyl acetate. The obtained ethyl acetate layer was washed with saturated brine, dried over anhydrous magnesium sulfate, filtered, and concentrated to give white crystals of the target compound 4- (1-carboxybutyl) -azetidin-2-one derivative (3 -2) 98
5.8 mg (75% yield) was obtained. In addition, the production ratio of the compound (3α-2) in which the n-propyl group in the wavy line in the formula of the obtained compound (3-2) is in the α position and the compound (3β-2) in which the β position is α: β = 73:27, these are HPLC
(The conditions of the column and the developing solvent are the same as those in Reference Example 1), and the structure was determined. α-form (3α-2) Melting point: 173-174 ° C MS (m / e): 314,272 IR (KBr) cm -1 : 1720 1 H-NMR δ (CD 3 OD): 0.08 (s, 3H), 0.10 ( s, 3H), 0.90 (s, 9H),
0.94 (t, J = 7.2Hz, 3H), 1.23 (d, J = 6.3Hz, 3H), 1.40 (m, 2H),
1.60 (m, 2H), 2.47 (m, 1H), 2.88 (dd, J = 2.0,4.3Hz, 1H), 3.78
(dd, J = 2.0,8.7Hz, 1H), 4.20 (qd, J = 4.3,6.3Hz, 1H) β-body (3β-2) Melting point: 164.5-166 ° C MS (m / e): 314,272 IR (KBr ) cm -1 : 1720 1 H-NMR δ (CD 3 OD): 0.07 (s, 3H), 0.08 (s, 3H), 0.89 (s, 9H),
0.95 (t, J = 7.2Hz, 3H), 1.16 (d, J = 6.4Hz, 3H), 1.45 (m, 3H),
1.64 (m, 1H), 2.48 (m, 1H), 3.01 (dd, J = 2.0,2.7Hz, 1H), 3.77
(dd, J = 2.0,8.4Hz, 1H), 4.22 (qd, J = 2.7,6.4Hz, 1H)

【0087】参考例3Reference Example 3

【0088】[0088]

【化28】 [Chemical 28]

【0089】窒素雰囲気下、酢酸パラジウム4.5mg
(0.02mmol)及びトリフェニルホスフィン10.5
mg(0.04mmol)をトルエン2.5mlに溶解した溶液
に、ギ酸0.56g(12.0mmol)を加え70℃で加
熱撹拌した。この反応液に実施例7で得られたアゼチジ
ン−2−オン誘導体(1b−1)0.54g(1.0mm
ol)をトルエン2mlに溶解した溶液を15分かけて滴下
し、さらに70℃で3.5時間撹拌を続けた。反応液を
室温まで冷却し、ジエチルエーテル15ml及び2N塩酸
5mlを加え、20分間撹拌した後、分液を行った。ジエ
チルエーテル層を5%水酸化ナトリウム水溶液10mlで
3回抽出した後、水層に2N塩酸を加えてpH2とし、ジ
エチルエーテル20mlで2回抽出を行った。得られたジ
エチルエーテル層を飽和食塩水で洗浄後、無水硫酸マグ
ネシウムで脱水、次いで濾過、濃縮を行って、目的とす
る化合物(3−1)0.23g(収率76%)を得た。
なお、得られた化合物(3−1)の異性体生成比は、
(3α−1):(3β−1)=6:94であった。
4.5 mg of palladium acetate under a nitrogen atmosphere
(0.02 mmol) and triphenylphosphine 10.5
0.56 g (12.0 mmol) of formic acid was added to a solution of mg (0.04 mmol) dissolved in 2.5 ml of toluene, and the mixture was heated with stirring at 70 ° C. 0.54 g (1.0 mm) of the azetidin-2-one derivative (1b-1) obtained in Example 7 was added to this reaction solution.
ol) dissolved in 2 ml of toluene was added dropwise over 15 minutes, and stirring was continued at 70 ° C. for 3.5 hours. The reaction mixture was cooled to room temperature, 15 ml of diethyl ether and 5 ml of 2N hydrochloric acid were added, and the mixture was stirred for 20 minutes and then separated. The diethyl ether layer was extracted three times with 10 ml of a 5% aqueous sodium hydroxide solution, the aqueous layer was adjusted to pH 2 with 2N hydrochloric acid, and extracted twice with 20 ml of diethyl ether. The obtained diethyl ether layer was washed with saturated brine, dried over anhydrous magnesium sulfate, filtered, and concentrated to obtain 0.23 g (yield 76%) of the desired compound (3-1).
The isomer production ratio of the obtained compound (3-1) is
(3α-1) :( 3β-1) = 6: 94.

【0090】参考例4Reference Example 4

【0091】[0091]

【化29】 [Chemical 29]

【0092】窒素雰囲気下、酢酸パラジウム24.8mg
(1.1mmol)及びトリフェニルホスフィン57.6mg
(2.2mmol)をテトラヒドロフラン15mlに溶解した
溶液に、ギ酸2.02g(44.0mmol)及びトリエチ
ルアミン5.55g(55.0mmol)をテトラヒドロフ
ラン15mlに溶解した溶液を加え加熱還流した。この反
応液に実施例10で得られたアゼチジン−2−オン誘導
体(1b−4)5.68g(11.0mmol)をテトラヒ
ドロフラン20mlに溶解した溶液を30分かけて滴下
し、さらに1.5時間撹拌を続けた。反応液を室温まで
冷却し、ジエチルエーテル80mlを加え、飽和食塩水3
0mlで洗浄し、無水硫酸マグネシウムで脱水後、溶媒を
減圧留去して粗生成物4.41gを得た。次いで、−6
0℃に冷却した液体アンモニア100mlに金属ナトリウ
ム1.29g(56.0 mmol)を加え、ナトリウムが溶
解して液が濃青色となったところで、上記で得た粗生成
物4.41gをジエチルエーテル20mlに溶解して溶液
を30分かけて滴下した。反応容器の冷却を止め、反応
液の撹拌を続けながら、一晩かけて室温に戻した。ジエ
チルエーテル50ml及び水50mlを加え撹拌、次いで分
液を行い、得られた水層に、ジエチルエーテル層を5%
水酸化ナトリウム水溶液20mlで抽出したものを合わせ
た後、希塩酸を用いてpH2とした。これを、ジエチルエ
ーテル100mlで抽出し、飽和食塩水30mlで洗浄した
後、無水硫酸マグネシウムで脱水、次いで濾過、濃縮を
行って、目的とする化合物(3−1)2.60g(収率
77%)を得た。なお、得られた化合物(3−1)の異
性体生成比は、(3α−1):(3β−1)=31:6
9であった。
Under a nitrogen atmosphere, 24.8 mg of palladium acetate
(1.1 mmol) and 57.6 mg of triphenylphosphine
A solution of 2.02 g (44.0 mmol) of formic acid and 5.55 g (55.0 mmol) of triethylamine in 15 ml of tetrahydrofuran was added to a solution of (2.2 mmol) in 15 ml of tetrahydrofuran, and the mixture was heated under reflux. A solution prepared by dissolving 5.68 g (11.0 mmol) of the azetidin-2-one derivative (1b-4) obtained in Example 10 in 20 ml of tetrahydrofuran was added dropwise to this reaction solution over 30 minutes, and further 1.5 hours. Stirring was continued. The reaction solution was cooled to room temperature, 80 ml of diethyl ether was added, and saturated saline solution was added.
After washing with 0 ml and dehydration with anhydrous magnesium sulfate, the solvent was distilled off under reduced pressure to obtain 4.41 g of a crude product. Then, -6
To 100 ml of liquid ammonia cooled to 0 ° C, 1.29 g (56.0 mmol) of metallic sodium was added, and when sodium was dissolved and the liquid became deep blue, 4.41 g of the crude product obtained above was added to diethyl ether. It was dissolved in 20 ml and the solution was added dropwise over 30 minutes. The cooling of the reaction vessel was stopped, and the temperature of the reaction solution was returned to room temperature overnight while continuing stirring. Diethyl ether (50 ml) and water (50 ml) were added and stirred, and then liquid separation was performed.
The extracts extracted with 20 ml of an aqueous solution of sodium hydroxide were combined and then adjusted to pH 2 with diluted hydrochloric acid. This was extracted with 100 ml of diethyl ether, washed with 30 ml of saturated saline, dried over anhydrous magnesium sulfate, filtered and concentrated to obtain 2.60 g of the target compound (3-1) (yield 77%). ) Got. The isomer production ratio of the obtained compound (3-1) was (3α-1) :( 3β-1) = 31: 6.
It was 9.

【0093】参考例5Reference Example 5

【0094】[0094]

【化30】 [Chemical 30]

【0095】実施例12で得られたアゼチジン−2−オ
ン誘導体(1b−6)1.09g(2.0mmol)、酢酸
パラジウム9.0mg(0.04mmol)、トリフェニルホ
スフィン21.0mg(0.08mmol)、ギ酸0.37g
(8.0mmol)及びトリエチルアミン0.91g(9.
0mmol)を用いて、前記参考例3に従って脱エステル、
脱炭酸反応を行った後、液体アンモニア30ml及び金属
ナトリウム0.24g(10.0mmol)を用いて脱ベン
ジル化反応を行い、目的とする化合物(3−1)0.4
8g(収率80%)を得た。なお、得られた化合物(3
−1)の異性体生成比は、(3α−1):(3β−1)
=39:61であった。
1.09 g (2.0 mmol) of the azetidin-2-one derivative (1b-6) obtained in Example 12, 9.0 mg (0.04 mmol) of palladium acetate, and 21.0 mg (0.04 mmol) of triphenylphosphine. 08 mmol), formic acid 0.37 g
(8.0 mmol) and 0.91 g of triethylamine (9.
0 mmol) and deesterification according to Reference Example 3 above.
After carrying out the decarboxylation reaction, the debenzylation reaction was carried out using 30 ml of liquid ammonia and 0.24 g (10.0 mmol) of metallic sodium to obtain the target compound (3-1) 0.4
8 g (yield 80%) was obtained. The obtained compound (3
The isomer production ratio of -1) is (3α-1) :( 3β-1)
= 39:61.

【0096】参考例6Reference Example 6

【0097】[0097]

【化31】 [Chemical 31]

【0098】実施例3で得られたアゼチジン−2−オン
誘導体(1a−3)1.58g(3.0mmol)、トリエ
チルアミン0.72g(7.1mmol)及び5%パラジウ
ム炭素0.3gをメタノール30mlに懸濁し、常圧で水
素添加を行った。濾過によりパラジウム炭素を除去した
後、メタノールを減圧留去し、残留物に飽和炭酸水素ナ
トリウム水溶液10ml及び酢酸エチル10mlを加えて撹
拌、分液を行った。水層を1N塩酸で酸性とし、生成し
た白色固体を濾別し、水洗後、減圧乾燥を行って、ジカ
ルボン酸化合物(8a)0.54g(収率52%)を得
た。 融点:110-111℃ MS(m/e):244,200 IR(KBr)cm-1:1755,17201 H-NMR δ(CD3OD):0.02(s,3H),0.04(s,3H),0.86(s,9H),
1.13(d,J=6.4Hz,3H),1.33(s,3H),3.01(dd,J=2.1,2.7Hz,
1H),4.19(d,J=2.1Hz,1H),4.20(m,1H)
1.58 g (3.0 mmol) of the azetidin-2-one derivative (1a-3) obtained in Example 3, 0.72 g (7.1 mmol) of triethylamine and 0.3 g of 5% palladium carbon were added to 30 ml of methanol. And suspended in and hydrogenated at normal pressure. After removing palladium carbon by filtration, methanol was distilled off under reduced pressure, 10 ml of a saturated aqueous sodium hydrogen carbonate solution and 10 ml of ethyl acetate were added to the residue, and the mixture was stirred and separated. The aqueous layer was acidified with 1N hydrochloric acid, the produced white solid was filtered off, washed with water and dried under reduced pressure to obtain 0.54 g of dicarboxylic acid compound (8a) (yield 52%). Melting point: 110-111 ° C MS (m / e): 244,200 IR (KBr) cm -1 : 1755,1720 1 H-NMR δ (CD 3 OD): 0.02 (s, 3H), 0.04 (s, 3H), 0.86 (s, 9H),
1.13 (d, J = 6.4Hz, 3H), 1.33 (s, 3H), 3.01 (dd, J = 2.1,2.7Hz,
1H), 4.19 (d, J = 2.1Hz, 1H), 4.20 (m, 1H)

【0099】参考例7Reference Example 7

【0100】[0100]

【化32】 [Chemical 32]

【0101】実施例2で得られたアゼチジン−2−オン
誘導体(1a−2)1.08g(2.7mmol)をエタノ
ール15ml及び水5mlに溶解し、これに、水酸化カリウ
ム0.99g(17.6mmol)を水3mlに溶解した溶液
を加えて、50℃に加熱し5時間撹拌を続けた。反応液
を室温まで冷却した後、水30mlに注ぎ、2N塩酸で酸
性とし、生成した白色固体を濾別し、水洗した後、減圧
乾燥を行って、ジカルボン酸化合物(8a)0.63g
(収率68%)を得た。
1.08 g (2.7 mmol) of the azetidin-2-one derivative (1a-2) obtained in Example 2 was dissolved in 15 ml of ethanol and 5 ml of water, and 0.99 g (17 g) of potassium hydroxide was added thereto. (6 mmol) in 3 ml of water was added, and the mixture was heated to 50 ° C. and stirred for 5 hours. The reaction solution was cooled to room temperature, poured into 30 ml of water, acidified with 2N hydrochloric acid, the white solid produced was filtered off, washed with water and dried under reduced pressure to give 0.63 g of dicarboxylic acid compound (8a).
(Yield 68%) was obtained.

【0102】参考例8Reference Example 8

【0103】[0103]

【化33】 [Chemical 33]

【0104】実施例4で得たアゼチジン−2−オン誘導
体(1a−4)及び(1a−5)の異性体混合物0.4
0g(0.93mmol)をエタノール2mlに溶解し、これ
に、水酸化カリウム0.34g(6.1mmol)を水3ml
に溶解した溶液を加えて、50℃で2日間攪拌を続け
た。反応液を減圧濃縮した後、1N塩酸を加えてpH2と
してからさらに減圧濃縮を行った。得られた固体にジエ
チルエーテル10mlを加え、良く攪拌した後、濾過、濃
縮を行ってジカルボン酸化合物(8a)0.21g(収
率66%)を得た。
Isomeric mixture of azetidin-2-one derivatives (1a-4) and (1a-5) obtained in Example 4 0.4
0 g (0.93 mmol) was dissolved in 2 ml of ethanol, and 0.34 g (6.1 mmol) of potassium hydroxide was added to 3 ml of water.
The solution dissolved in was added, and stirring was continued at 50 ° C. for 2 days. The reaction solution was concentrated under reduced pressure, 1N hydrochloric acid was added to adjust the pH to 2, and further concentrated under reduced pressure. Diethyl ether (10 ml) was added to the obtained solid, and the mixture was well stirred, filtered and concentrated to obtain 0.21 g (yield 66%) of dicarboxylic acid compound (8a).

【0105】参考例9Reference Example 9

【0106】[0106]

【化34】 [Chemical 34]

【0107】実施例5で得たアゼチジン−2−オン誘導
体(1a−6)0.62g(1.0mmol)をエタノール
10ml及び水3mlに溶解し、これに、水酸化カリウム
0.38g(6.8mmol)を水3mlに溶解した溶液を加
えて、50℃で25時間攪拌を続けた。反応液を室温ま
で冷却した後、水30mlに注ぎ、ジエチルエーテル10
mlで2回抽出を行った。得られた水層を2N塩酸で酸性
とし、酢酸エチル15mlで2回抽出を行い、次いで、抽
出液を無水硫酸マグネシウムで脱水した後、濾過、減圧
乾燥を行って、ジカルボン酸化合物(8a)0.18g
(収率52%)を得た。
0.62 g (1.0 mmol) of the azetidin-2-one derivative (1a-6) obtained in Example 5 was dissolved in 10 ml of ethanol and 3 ml of water, and 0.38 g (6. A solution of 8 mmol) in 3 ml of water was added and stirring was continued at 50 ° C. for 25 hours. The reaction solution was cooled to room temperature and then poured into 30 ml of water, and diethyl ether 10 was added.
Extraction was performed twice with ml. The obtained aqueous layer was acidified with 2N hydrochloric acid, extracted twice with 15 ml of ethyl acetate, and then the extract was dehydrated over anhydrous magnesium sulfate, filtered and dried under reduced pressure to obtain dicarboxylic acid compound (8a) 0 .18 g
(Yield 52%) was obtained.

【0108】参考例10Reference Example 10

【0109】[0109]

【化35】 [Chemical 35]

【0110】実施例13で得られたアゼチジン−2−オ
ン誘導体(1b−7)2.40g(4.9mmol)にエタ
ノール5ml及び水10mlを加え、撹拌しながら、水酸化
カリウム1.10g(19.6mmol)を水5mlに溶解し
た溶液を加え、室温で一晩撹拌した。この反応液を水5
0mlに注ぎ、1N塩酸を加えてpH7とし、次いでジエチ
ルエーテル50mlを用いて抽出を行った。さらに、pH1
となるまで1N塩酸を加えた後、ジエチルエーテル50
mlを加え抽出を行い、得られたジエチルエーテル層を飽
和食塩水15mlで洗浄した後、無水硫酸マグネシウムで
脱水、次いで濾過、濃縮を行って、ジカルボン酸化合物
(8b)1.50g(収率69%)を得た。 融点:128-129℃ MS(m/e):334,290 IR(KBr)cm-1:1750,17301 H-NMR δ(CD3OD):0.01(s,3H),0.07(s,3H),0.86(s,9H),
1.16(d,J=6.4Hz,3H),1.21(s,3H),3.04(m,1H),4.21(m,1
H),4.30(d,J=15.2Hz,1H),4.45(d,J=2.1Hz,1H),4.46(d,J
=15.2Hz,1H),7.30(m,5H)
To 2.40 g (4.9 mmol) of the azetidin-2-one derivative (1b-7) obtained in Example 13 was added 5 ml of ethanol and 10 ml of water, and 1.10 g of potassium hydroxide (19 g) was added with stirring. (6 mmol) in 5 ml of water was added, and the mixture was stirred at room temperature overnight. This reaction solution is mixed with water 5
It was poured into 0 ml and adjusted to pH 7 with 1N hydrochloric acid, and then extracted with 50 ml of diethyl ether. Furthermore, pH 1
After adding 1N hydrochloric acid until
The mixture was added with ml and extracted, and the obtained diethyl ether layer was washed with 15 ml of saturated brine, dried over anhydrous magnesium sulfate, filtered, and concentrated to give 1.50 g of dicarboxylic acid compound (8b) (yield 69 %) Was obtained. Melting point: 128-129 ° C MS (m / e): 334,290 IR (KBr) cm -1 : 1750,1730 1 H-NMR δ (CD 3 OD): 0.01 (s, 3H), 0.07 (s, 3H), 0.86 (s, 9H),
1.16 (d, J = 6.4Hz, 3H), 1.21 (s, 3H), 3.04 (m, 1H), 4.21 (m, 1
H), 4.30 (d, J = 15.2Hz, 1H), 4.45 (d, J = 2.1Hz, 1H), 4.46 (d, J
= 15.2Hz, 1H), 7.30 (m, 5H)

【0111】参考例11Reference Example 11

【0112】[0112]

【化36】 [Chemical 36]

【0113】参考例6〜8で得られたジカルボン酸化合
物(8a)1.38g(4.0mmol)をジエチレングリ
コールジメチルエーテル15mlに溶解し、120℃で3
時間加熱した。反応液を室温まで冷却した後、ジエチル
エーテル20ml及び5%水酸化ナトリウム水溶液15ml
を用いて抽出を行い、水層をさらにジエチルエーテル1
0mlで洗浄した後、2N塩酸でpH2とし、ジエチルエー
テル30mlを用いて抽出を行った。得られたジエチルエ
ーテル層は、飽和食塩水10mlで洗浄した後、無水硫酸
マグネシウムで脱水、次いで濾過、濃縮を行って、目的
とする化合物(3−1)0.97g(収率80%)を得
た。なお、得られた化合物(3−1)の異性体生成比
は、(3α−1):(3β−1)=90:10であっ
た。
1.38 g (4.0 mmol) of the dicarboxylic acid compound (8a) obtained in Reference Examples 6 to 8 was dissolved in 15 ml of diethylene glycol dimethyl ether, and the mixture was stirred at 120 ° C. for 3 days.
Heated for hours. After cooling the reaction mixture to room temperature, 20 ml of diethyl ether and 15 ml of 5% aqueous sodium hydroxide solution.
Extraction was carried out with and the aqueous layer was further extracted with diethyl ether 1
After washing with 0 ml, the pH was adjusted to 2 with 2N hydrochloric acid, and extraction was performed with 30 ml of diethyl ether. The obtained diethyl ether layer was washed with 10 ml of saturated saline solution, dried over anhydrous magnesium sulfate, filtered, and concentrated to obtain 0.97 g (yield 80%) of the desired compound (3-1). Obtained. The isomer production ratio of the obtained compound (3-1) was (3α-1) :( 3β-1) = 90: 10.

【0114】参考例12Reference Example 12

【0115】[0115]

【化37】 [Chemical 37]

【0116】参考例10で得られたジカルボン酸化合物
(8b)0.87g(2.0mmol)を前記参考例11に
従って加熱脱炭酸反応を行った後、前記参考例4に従っ
て液体アンモニア及び金属ナトリウムを用いて脱ベンジ
ル化反応を行い、目的とする化合物(3−1)0.42
g(収率70%)を得た。なお、得られた化合物(3−
1)の異性体生成比は、(3α−1):(3β−1)=
28:72であった。
0.87 g (2.0 mmol) of the dicarboxylic acid compound (8b) obtained in Reference Example 10 was heated and decarboxylated according to Reference Example 11, and then liquid ammonia and sodium metal were added according to Reference Example 4. Debenzylation reaction is carried out using the desired compound (3-1) 0.42
g (yield 70%) was obtained. The obtained compound (3-
The isomer production ratio of 1) is (3α-1) :( 3β-1) =
It was 28:72.

【0117】[0117]

【発明の効果】本発明のアゼチジン−2−オン誘導体を
用いれば、1β−アルキルカルバペネム系抗菌剤の合成
中間体である4−(1−カルボキシアルキル)−アゼチ
ジン−2−オン誘導体を効率よく製造することができ
る。
By using the azetidin-2-one derivative of the present invention, a 4- (1-carboxyalkyl) -azetidin-2-one derivative, which is a synthetic intermediate of 1β-alkylcarbapenem antibacterial agents, can be efficiently produced. can do.

─────────────────────────────────────────────────────
─────────────────────────────────────────────────── ───

【手続補正書】[Procedure amendment]

【提出日】平成4年9月25日[Submission date] September 25, 1992

【手続補正1】[Procedure Amendment 1]

【補正対象書類名】明細書[Document name to be amended] Statement

【補正対象項目名】0009[Correction target item name] 0009

【補正方法】変更[Correction method] Change

【補正内容】[Correction content]

【0009】(式中、Rは前記と同じ意味を示し、A
cはアセチル基を示す)で表される4−アセトキシアゼ
チジン−2−オン誘導体の4位を、種々の求核剤により
アルキル化することにより、側鎖を導入する方法が最も
期待されており、プロピオン酸エステルエノラートによ
るアルキル化〔C.U.Kimら;Tetrahedr
on Lett.,28(5)507−510(198
7)、T.Chibaら;Chem.Lett.,13
43−1346(1985)、T.Shibataら;
Tetrahedron Lett.,26(39)4
739−4742(1985)〕、プロピオン酸イミド
のエノラートによるアルキル化〔Y.Nagaoら;
J.Am.Chem.Soc.,108,4673−4
675(1986)、長尾善光;化学,42(3)19
0−196(1987)、L.M.Fuentesら;
J.Am.Chem.Soc.,108,4675−4
676(1986)、R.Dezielら;Tetra
hedron Lett.,27(47)5687−5
690(1986)、Y.Itoら;Tetrahed
ron Lett.,28(52)6625−6628
(1987)、プロピオン酸チオールエステルエノラー
トによるアルキル化〔M.Endo;Can,J.Ch
em.,65,2140−2145(1987)、C.
U.Kimら;Tetrahedron Lett.,
28(5)507−510(1987)、A.Mart
elら;Can.J.Chem.,66,1537−1
539(1988)〕などが報告されている。化合物
(3β)のその他の合成法としては、例えば化合物
(5)
(Wherein R 4 has the same meaning as described above, and A 4
c represents an acetyl group), and a method of introducing a side chain by alkylating the 4-position of the 4-acetoxyazetidin-2-one derivative represented by various nucleophiles is most expected. Alkylation with propionate enolate [C. U. Kim et al .; Tetrahedr
on Lett. , 28 (5) 507-510 (198).
7), T. Chiba et al .; Chem. Lett. , 13
43-1346 (1985), T.W. Shibata et al .;
Tetrahedron Lett. , 26 (39) 4
739-4742 (1985)], alkylation of propionimide with an enolate [Y. Nagao et al .;
J. Am. Chem. Soc. , 108 , 4673-4
675 (1986), Yoshimitsu Nagao; Chemistry, 42 (3) 19
0-196 (1987), L.A. M. Fuentes et al .;
J. Am. Chem. Soc. , 108 , 4675-4
676 (1986), R.I. Deziel et al .; Tetra
hedron Lett. , 27 (47) 5687-5.
690 (1986), Y. Ito et al .; Tetrahed
ron Lett. , 28 (52) 6625-6628.
(1987), alkylation with a propionic acid thiol ester enolate [M. Endo; Can, J .; Ch
em. , 65 , 2140-2145 (1987), C.I.
U. Kim et al .; Tetrahedron Lett. ,
28 (5) 507-510 (1987), A.S. Mart
el et al .; Can. J. Chem. , 66 , 1537-1
539 (1988)] and the like have been reported. Other synthetic methods of compound (3β) include, for example, compound (5)

【手続補正2】[Procedure Amendment 2]

【補正対象書類名】明細書[Document name to be amended] Statement

【補正対象項目名】0034[Correction target item name] 0034

【補正方法】変更[Correction method] Change

【補正内容】[Correction content]

【0034】この脱エステル及び脱炭酸反応は、例えば
通常の加水分解及び加熱反応によって行うことができ
る。すなわち、化合物(1)を水酸化ナトリウム、水酸
化カリウム、水酸化リチウム等の塩基の存在下で加水分
解し、次いで80〜120℃に加熱することにより脱炭
酸を行えばよい。また、R及びRがアラルキル基で
ある場合には、アミンの存在下パラジウム炭素を用いた
水素添加によって脱エステルを行うこともできる。
The deesterification and decarboxylation reactions can be carried out, for example, by ordinary hydrolysis and heating reactions. That is, the compound (1) may be hydrolyzed in the presence of a base such as sodium hydroxide, potassium hydroxide or lithium hydroxide, and then heated at 80 to 120 ° C. for decarboxylation. When R 1 and R 2 are aralkyl groups, deesterification can also be carried out by hydrogenation using palladium carbon in the presence of amine.

【手続補正3】[Procedure 3]

【補正対象書類名】明細書[Document name to be amended] Statement

【補正対象項目名】0077[Correction target item name] 0077

【補正方法】変更[Correction method] Change

【補正内容】[Correction content]

【0077】実施例2で得られたアゼチジン−2−オン
誘導体(1a−2)4.01g(10.0mmol)、
60%水素化ナトリウム0.40g(11.0mmo
l)及び塩化ベンジル1.39g(6.0mmol)を
用いて、前記実施例10に従ってN−ベンジル化を行
い、無色油状のアゼチジン−2−オン誘導体(1b−
7)4.30g(収率88%)を得た。 MS(m/e):476,434 IR(neat)cm−1:1760,1730 H−NMR δ(CDCl):0.00(s,3
H),0.06(s,3H),0.87(s,9H),
1.16(d,J=6.3Hz,3H),1.20,
1.22(2overlapping t,J=7.3
Hz,6H),1.30(s,3H),2.99(d
d,J=2.1,4.5Hz,1H),4.17(m,
6H),4.36(d,J=2.1Hz,1H),4.
55(d,J=15.3Hz,1H),7.31(m,
5H)
4.01 g (10.0 mmol) of the azetidin-2-one derivative (1a-2) obtained in Example 2,
60% sodium hydride 0.40 g (11.0 mmo
1) and 1.39 g (6.0 mmol) of benzyl chloride were subjected to N-benzylation according to the above-mentioned Example 10 to give a colorless oily azetidin-2-one derivative (1b-).
7) 4.30 g (yield 88%) was obtained. MS (m / e): 476,434 IR (neat) cm −1 : 1760, 1730 1 H-NMR δ (CDCl 3 ): 0.00 (s, 3
H), 0.06 (s, 3H), 0.87 (s, 9H),
1.16 (d, J = 6.3 Hz, 3H), 1.20,
1.22 (2 overlapping t, J = 7.3
Hz, 6H), 1.30 (s, 3H), 2.99 (d
d, J = 2.1, 4.5 Hz, 1H), 4.17 (m,
6H), 4.36 (d, J = 2.1Hz, 1H), 4.
55 (d, J = 15.3 Hz, 1H), 7.31 (m,
5H)

【手続補正4】[Procedure amendment 4]

【補正対象書類名】明細書[Document name to be amended] Statement

【補正対象項目名】0095[Correction target item name] 0095

【補正方法】変更[Correction method] Change

【補正内容】[Correction content]

【0095】実施例12で得られたアゼチジン−2−オ
ン誘導体(1b−6)1.09g(2.0mmol)、
酢酸パラジウム9.0mg(0.04mmol)、トリ
フェニルホスフィン21.0mg(0.08mmo
l)、ギ酸0.37g(8.0mmol)及びトリエチ
ルアミン0.91g(9.0mmol)を用いて、前記
参考例4に従って脱エステル、脱炭酸反応を行った後、
液体アンモニア30ml及び金属ナトリウム0.24g
(10.0mmol)を用いて脱ベンジル化反応を行
い、目的とする化合物(3−1)0.48g(収率80
%)を得た。なお、得られた化合物(3−1)の異性体
生成比は、(3α−1):(3β−1)=39:61で
あった。
1.09 g (2.0 mmol) of the azetidin-2-one derivative (1b-6) obtained in Example 12,
Palladium acetate 9.0 mg (0.04 mmol), triphenylphosphine 21.0 mg (0.08 mmo
1), 0.37 g (8.0 mmol) of formic acid and 0.91 g (9.0 mmol) of triethylamine, followed by deesterification and decarboxylation according to Reference Example 4,
Liquid ammonia 30 ml and metallic sodium 0.24 g
The debenzylation reaction was carried out using (10.0 mmol) to obtain the target compound (3-1) 0.48 g (yield 80
%) Was obtained. The isomer production ratio of the obtained compound (3-1) was (3α-1) :( 3β-1) = 39: 61.

【手続補正5】[Procedure Amendment 5]

【補正対象書類名】明細書[Document name to be amended] Statement

【補正対象項目名】0113[Name of item to be corrected] 0113

【補正方法】変更[Correction method] Change

【補正内容】[Correction content]

【0113】参考例6〜9で得られたジカルボン酸化合
物(8a)1.38g(4.0mmol)をジエチレン
グリコールジメチルエーテル15mlに溶解し、120
℃で3時間加熱した。反応液を室温まで冷却した後、ジ
エチルエーテル20ml及び5%水酸化ナトリウム水溶
液15mlを用いて抽出を行い、水層をさらにジエチル
エーテル10mlで洗浄した後、2N塩酸でpH2と
し、ジエチルエーテル30mlを用いて抽出を行った。
得られたジエチルエーテル層は、飽和食塩水10mlで
洗浄した後、無水硫酸マグネシウムで脱水、次いで濾
過、濃縮を行って、目的とする化合物(3−1)0.9
7g(収率80%)を得た。なお、得られた化合物(3
−1)の異性体生成比は、(3α−1):(3β−1)
=90:10であった。
1.38 g (4.0 mmol) of the dicarboxylic acid compound (8a) obtained in Reference Examples 6 to 9 was dissolved in 15 ml of diethylene glycol dimethyl ether to give 120
Heated at ° C for 3 hours. The reaction solution was cooled to room temperature, extracted with 20 ml of diethyl ether and 15 ml of 5% aqueous sodium hydroxide solution, the aqueous layer was further washed with 10 ml of diethyl ether, adjusted to pH 2 with 2N hydrochloric acid, and 30 ml of diethyl ether was used. Was extracted.
The obtained diethyl ether layer was washed with 10 ml of saturated saline and then dehydrated with anhydrous magnesium sulfate, followed by filtration and concentration to obtain the desired compound (3-1) 0.9.
7 g (yield 80%) was obtained. The obtained compound (3
The isomer production ratio of -1) is (3α-1) :( 3β-1)
= 90:10.

フロントページの続き (72)発明者 小林 東洋彦 東京都大田区蒲田5丁目36番31号 高砂香 料工業株式会社総合研究所内Continued Front Page (72) Inventor Toyohiko Kobayashi 5-36-31 Kamata, Ota-ku, Tokyo Takasago International Corp.

Claims (1)

【特許請求の範囲】[Claims] 【請求項1】 一般式(1) 【化1】 (式中、R1及びR2は同一又は異なって、それぞれアル
キル基、アルケニル基又はアラルキル基を示し、R3
低級アルキル基を示し、R4は水素原子又は水酸基の保
護基を示し、R5は水素原子又はアミノ基の保護基を示
す)で表されるアゼチジン−2−オン誘導体。
1. A compound represented by the general formula (1): (In the formula, R 1 and R 2 are the same or different and each represents an alkyl group, an alkenyl group or an aralkyl group, R 3 represents a lower alkyl group, R 4 represents a hydrogen atom or a hydroxyl group-protecting group, and R 5 represents a hydrogen atom or an amino-protecting group), and is an azetidin-2-one derivative.
JP3324737A 1991-12-09 1991-12-09 Azetidin-2-one derivatives Expired - Lifetime JP2958834B2 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
JP3324737A JP2958834B2 (en) 1991-12-09 1991-12-09 Azetidin-2-one derivatives
DE69231883T DE69231883T2 (en) 1991-12-09 1992-11-30 4- (1,1-dialkoxycarbonyl-alkyl) azetidin-2-one derivatives for the preparation of 4- (1-carboxy-alkyl) azetidin-2-one derivatives
EP92310901A EP0546742B1 (en) 1991-12-09 1992-11-30 4-(1,1-Dialkoxycarbonyl-alkyl)azetidin-2-one derivatives and synthesis of 4-(1-carboxy-alkyl)azetidin-2-one derivatives therefrom
KR1019920023554A KR100253715B1 (en) 1991-12-09 1992-12-08 4- (1,1-dialkoxycarbonylalkyl) azetidin-2-one derivative and method for preparing 4- (1-carboxyalkyl) azetidin-2-one derivative using the same
US07/987,779 US5371214A (en) 1991-12-09 1992-12-09 4-(1,1-dialkoxycarbonylalkyl)azetidin-2-one derivative and process for producing 4-(1-carboxyalkyl)azetidin-2-one derivative using the same
US08/277,319 US5574152A (en) 1991-12-09 1994-07-25 4-(1,1-dialkoxycarbonylalkyl) azetidin-2-one derivative and process for producing 4-(1-carboxyalkyl) azetidin-2-one derivative using the same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP3324737A JP2958834B2 (en) 1991-12-09 1991-12-09 Azetidin-2-one derivatives

Publications (2)

Publication Number Publication Date
JPH05155850A true JPH05155850A (en) 1993-06-22
JP2958834B2 JP2958834B2 (en) 1999-10-06

Family

ID=18169128

Family Applications (1)

Application Number Title Priority Date Filing Date
JP3324737A Expired - Lifetime JP2958834B2 (en) 1991-12-09 1991-12-09 Azetidin-2-one derivatives

Country Status (2)

Country Link
JP (1) JP2958834B2 (en)
KR (1) KR100253715B1 (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0638552A4 (en) * 1993-02-12 1995-03-29 Suntory Ltd Process for synthesizing 4-substituted azetidinone derivative.
WO2001072704A1 (en) * 2000-03-31 2001-10-04 Daewoong Pharmaceutical Co., Ltd. AZETIDINONE DERIVATIVES, A PROCESS FOR THEIR PREPARATION AND A METHOD FOR PRODUCING 1-β-ALKYL AZETIDINONE USING THE SAME
KR20010107078A (en) * 2000-05-25 2001-12-07 윤재승 Method of preparing 4-alkoxy-2-azetidinone derivative and its optical isomer
JP5143556B2 (en) * 2005-07-29 2013-02-13 金一 只野 Novel synthesis of carbapenem synthesis intermediates using sugar templates

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0638552A4 (en) * 1993-02-12 1995-03-29 Suntory Ltd Process for synthesizing 4-substituted azetidinone derivative.
WO2001072704A1 (en) * 2000-03-31 2001-10-04 Daewoong Pharmaceutical Co., Ltd. AZETIDINONE DERIVATIVES, A PROCESS FOR THEIR PREPARATION AND A METHOD FOR PRODUCING 1-β-ALKYL AZETIDINONE USING THE SAME
KR20010107078A (en) * 2000-05-25 2001-12-07 윤재승 Method of preparing 4-alkoxy-2-azetidinone derivative and its optical isomer
JP5143556B2 (en) * 2005-07-29 2013-02-13 金一 只野 Novel synthesis of carbapenem synthesis intermediates using sugar templates

Also Published As

Publication number Publication date
KR100253715B1 (en) 2001-11-22
JP2958834B2 (en) 1999-10-06

Similar Documents

Publication Publication Date Title
EP0023097B1 (en) De-arylmethylation of n-mono- or n-diarylmethyl-beta-lactams; novel azetizinones having anti-bacterial activity
JP4659309B2 (en) Process for producing 5-hydroxy-3-oxopentanoic acid derivative
EP0546742B1 (en) 4-(1,1-Dialkoxycarbonyl-alkyl)azetidin-2-one derivatives and synthesis of 4-(1-carboxy-alkyl)azetidin-2-one derivatives therefrom
JP2958834B2 (en) Azetidin-2-one derivatives
JP4303792B2 (en) Method for producing quinolone derivative
JP2958835B2 (en) Method for producing 4- (1-carboxyalkyl) azetidin-2-one derivative
US4754029A (en) 3-oxo-2-azabicyclohexane derivatives
JP3803126B2 (en) Method for producing optically active trans vinyl sulfide alcohol
JP2781216B2 (en) Method for producing 4-acyloxyazetidinone-2-one
JPS6332351B2 (en)
JPH05221947A (en) Production of cyclopropane derivative
JPH0267287A (en) Production of penem
AU666559B2 (en) 4-acylthio azetidinones
JP2733256B2 (en) 4-mercaptopyrazolidine derivative
JPH0142946B2 (en)
JPS643188B2 (en)
JPH0717945A (en) Production of substituted cyclic compound
JP2003137870A (en) Method for producing 3,5-dioxo-6-heptenoic acid derivatives, and intermediate therefor
KR20020073751A (en) Beta-substituted-gamma-butyrolactones and preparation process thereof
JPH07242609A (en) New amino acid derivative
JPH09221444A (en) Stereoselective production of cis-substituted bicycloheptanedione derivative
JPH0256349B2 (en)
JPH04243870A (en) Oxaazabicyclo(3.3.0)octane derivative
JPH03261759A (en) Nanaomycin a intermediate and synthesis thereof
JPH0147467B2 (en)